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X-ray-activated photodynamic therapy (X-PDT) techniques have gained traction for its potential to 
impart therapeutic effects at greater depths than possible with traditional photodynamic therapy [1], [2]. 
Interestingly, the underlying X-PDT process could also generate X-ray fluorescence (XF) with metal-based 
nanoparticles (NPs) and X-ray luminescence (XL), which could be used to monitor the delivery of PDT 
agents and the subsequent therapeutic process. This allows the possibility of using X-ray fluorescence 
(XFCT) and X-ray luminescence computed tomography (XLCT) to monitor the therapeutic delivery during 
radiation therapy. X-ray Raleigh scattering (XRS) produced by the scattered monochromatic incident X-
ray can also be correlated with the data from XFCT/XLCT while X-ray transmission CT (XT CT) could 
provide structural information.   
This work demonstrates a proof-of-concept of a XF-XL -XT CT imaging platform that allows for 
quantitative imaging of the X-ray PDT delivery process through complementary contrast mechanisms, and 
demonstrates this platform’s ability to image X-PDT nanophosphors, such as Y2O3:Eu3+. This work also 
attempts to address the limitations of the system—sensitivity, acquisition time, and dosage—by examining 
how incoming X-ray irradiation schemes affect the X-ray fluorescent and X-ray luminescent yields as well 
as overall X-ray fluorescent image quality. Results show that choosing an optimized incident X-ray 
spectrum can maximize fluorescent and luminescent yields as well as improve image quality. This in 
conjunction with improvements in geometric efficiency through a multi-slit ring of detectors has the 
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LIST OF ABBREVIATIONS 
 
ASIC Application Specific Integrated Circuit 
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X-PDT X-ray-Induced Photodynamic Therapy 
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 : INTRODUCTION AND BACKGROUND 
1.1 Scope of this Work 
This work examines the development of an imaging platform to ultimately address the 
need for in vivo simultaneous monitoring and stimulating of nanoparticle-mediated therapies 
such as X-ray induced photodynamic therapy. In order for this to be achieved, this work first 
demonstrates a proof-of-concept by imaging X-ray induced photodynamic therapy nanoparticles, 
such as Y2O3:Eu3+, through complementary contrast mechanisms—namely, X-ray luminescence, 
X-ray fluorescence, and X-ray CT—within a phantom.  
This work also attempts to address and evaluate the various parameters of the system—
sensitivity, acquisition time, and dosage—by examining how incoming X-ray irradiation schemes 
affect the X-ray fluorescent and X-ray luminescent yields as well as overall X-ray fluorescent 
image quality. Results show that choosing an optimized incident X-ray spectrum can maximize 
fluorescent and luminescent yields as well as improve image quality. This in conjunction with 
improvements in geometric efficiency through a multi-slit ring of detectors would allow future 
work in studying the therapeutic effects of such nanoparticles in vivo or ex vivo settings. 
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1.2 Motivation for a Tri-modality System for Photodynamic Therapy 
The first FDA-approved nanomedicine cancer drug, Doxil®, inspired many research 
groups to begin investigating nanomedicine agents for cancer treatment [1], [3]–[5]. 
Nanomedicines, in the form of nanoparticles (NP’s), can be  conjugated with targeting ligands 
allowing enhancd accumulation at specific tumor sites to enhance therapeutic effects while 
minimizing damage to healthy cells [6], [7]. However, the progression of nanomedicine 
development has been hindered by the inability of the researchers to determine how the 
nanomedicine produce their therapeutic effect, travel throughout the body, or interact with the cell 
in vivo [5]. This desire for the ability to simultaneously treat and monitor various diseases has 
given rise to concept of “theranostics.” Theranostics, a term coined in 2002, refers to a material or 
modality that allows for both imaging and therapy [8]. Theranostics has the potential to allow 
individuals to explore on a deeper level the mechanisms of disease and its treatment. To gain such 
 
Figure 1.1: The scale of biologically relevant features. Adapted from [79].  
© 2011 by Sinauer Associates, Inc 
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revelatory insight on the protein-level, the field of molecular imaging has also arisen. To 
understand the basic function of many of the diseases, imaging on the scale of tens of micrometers 
[9] would be necessary as seen in Figure 1.1.  
X-ray luminescence computed tomography (XLCT) and X-ray fluorescence computed 
tomography (XFCT) are X-ray’s means of competing in this molecular imaging field. Both these 
technologies rely on an incident X-ray beam to produce imageable secondary X-rays or optical 
photons, and both demonstrate higher sensitivity than their traditional X-ray transmission 
computed tomography (CT) counterpart [10].   
This work explores the concept of a single X-ray fluorescence, transmission CT (computed 
tomography), and luminescence system to provide the means to study the operation of 
chemotherapeutic nanoparticles. Specifically, this work examines the trimodal system’s 
application in conjunction with one particular type of nanoparticle-mediated cancer treatment, 
photodynamic therapy (PDT), in which nanoparticles produce cytotoxic singlet oxygen upon 
visible light irradiation [4]. Conventional PDT typically uses visible, near infrared (NIR), infrared 
(IR), or ultraviolet light to induce singlet oxygen production in nanoparticles [4], [11]. However, 
this incident light lacks significant penetration depth limiting photodynamic therapy to a few 
millimeters to a centimeter below skin. However, X-ray-induced photodynamic therapy (X-PDT) 
techniques have gained much attention in the hopes of imparting therapeutic effects at greater 
depths than is possible with traditional photodynamic therapy [11], [12].  X-PDT utilizes X-rays 
as the initial excitation mechanism of the NPs due to the X-rays greater penetration depth. 
Interestingly, the very process that underlies X-ray induced therapeutic effects could also generate 
X-ray fluorescence (with metal-based nanoparticles) and/or X-ray luminescence (XL), which 
could be used to monitor the delivery and distribution of PDT agents and the subsequent 
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therapeutic activation process. This leads to the possibility of using (XFCT) and X-ray 
luminescence computed tomography (XLCT) for monitoring therapeutic delivery during radiation 
therapy, which this work explores.   
For instance, a highly collimated X-ray beam irradiates the object during the microbeam 
therapeutic delivery process, with the pre-administrated metal-containing NPs preferably absorb 
the X-rays to produce therapeutic effects. These effects are produced either directly from radiation 
effects induced by low-energy secondary electrons (including Auger electrons) [13] or indirectly 
from processes such as thermal ablation [14]  and photosensitization [1, 2]. During the irradiation 
process, resulting XF signal could determine the distribution of the NPs in the object. The XL 
signals could provide quantitative information directly proportional to the therapeutic effect in 
question. Finally, the micro-CT images provide structural details of the object for confirmation of 
the delivery of the beam to the target area. Combining these three imaging techniques would 
provide a unique tool for guiding therapeutic delivery with highly detailed spatial and functional 
information.  
1.3 Photodynamic Therapy  
1.3.1 Basic Principles of Photodynamic Therapy and Photochemistry 
Photodynamic therapy predominantly uses light as its means of treating cancer, by using a 
light-sensitive agent called a photosensitizer to induce cytotoxicity. Through unknown or various 
means (depending on the type of photosensitizer), the photosensitizer accumulates in the tumor 
location, and upon light irradiation, singlet oxygen is produced. 
Singlet oxygen is a very excited and reactive molecule capable of interacting with biological 
relevant molecules found in membranes such as unsaturated lipids, cholesterol, tryptophan, 
histidine, and methionine [15].  Additionally, the singlet oxygen has a short lifetime, within 40 
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nanosecond, and a radius of action less than 20 nanometers [15]. This allows for a very specific 
targeting and localization within a tumor site. 
Singlet oxygen is produced when light excites the photosensitizer, elevating it to an excited 
electron energy state. In this excited, several different mechanisms can occur. The sensitizer can 
return to ground state by emitting light in a process called fluorescence. The sensitizer can react 
directly with other molecules in tissue to produce radical intermediates. However, to produce the 
actual photodynamic effect, the energetic sensitizer would enter a triplet state through “intersystem 
crossing”, in which the excited electron will go through a spin conversion to a lower excited state 
[16]. For an effective photosensitizer, this triplet state must have a long lifetime. In this triplet 
state, the sensitizer reacts with oxygen leading to singlet oxygen production as seen in Figure 1.2.  
 
Figure 1.2 A diagram representation of singlet oxygen production via the photosensitizer (Adapted from [16])  





Singlet oxygen can cause damage of membranes which causes swelling, bleb formation, 
and the halting of membrane enzymes. The membrane damage can cause the loss of necessary 
proteins such as cytochrome c, which ultimately led to ATP depletion. Interestingly, PDT has 
varying potential for causing DNA damage as some sensitizing agents have a low probability of 
accumulating in cell nuclei while others can cause breakage in the double strands of DNA [11].  
 These nanoparticles or agents often selectively accumulate at target sites. They can target 
tumors through active targeting by incorporating a ligand on the surface of the nanoparticle, which 
would either bind the nanoparticle to the tumor or transport the nanoparticle to the tumor [8], [17]. 
Additionally, the nanoparticle containing these sensitizing agents can also passively target tumors 
through the enhanced permeability and retention effect (EPR effect). The leaky undeveloped 
structure of tumor vasculature allows for the permeation and retention of these nanoparticles within 
the tumor itself  [18]. Typically these nanoparticles range in size of 1 nm to 100’s of nms, with the 
sizes often affecting tumor retention and body clearance rates [19]. Thus, such nanoparticles in 
combination with X-ray activation would produce a highly selective cytotoxicity for cancer 
therapies. 
1.3.2 Current State of Photodynamic Therapy and X-PDT 
Current work in PDT shows much promise in delivering an anti-tumor effect in vivo. 
Photofrin in 1993 was the first photodynamic therapy agent to be used clinically for treatment of 
non-small-cell lung cancer, esophageal cancer, and dysplasia in Barrett’s esophagus [20].  Since 
then many issues of emerged with PDT that limit’s it’s applications. Often photosensitizers are 




For instance, Prof. Wenbin Lin’s group at the University of Chicago produced nanoscale 
metal organic frameworks to transport photosensitizers to tumor sites [20], [21]. The frameworks, 
referred to as DBP-UiO, from these publications utilized Hf centers combined with H2DBP 
photosensitizers. The Hf in the frame, which would produce high energy X-ray fluorescence, and 
the framework itself also will produce visible light. Results showed in SQ20B neck tumor bearing 
mice models, half the mice receiving a single dose of the DBP-UiO (administered at 3.5 mg/kg 
mouse) with a single 135 J/cm2 light excitation showed complete eradication of tumors in half the 
mice specimens with shrinkage observed in the other mice as seen in Figure 1.3.  
Additionally, another group under Prof. Jin Xie from Georgia University, developed 
LiGa4O8:Cr-based NPs for X-PDT application. These nanoparticles are encapsulated and are 
Figure 1.3: The figure depicts the results of injecting tumor-bearing mouse with PBS, H2DBP and DBP-
UiO. (a) The control and the photosensitizer on its own did not show efficaciousness in inhibiting tumor 
growth. (b) Tumor volume is shown to be significantly less in the DBP-UiO trials. (c and d) Tumor size in 
the 4 mice specimens for each model is depicted. Strong inhibition is seen for the DBP-UiO trial. Adapted 
from [20]. 
Copyright © 2014 American Chemical Society 
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combined with 2,3-naphthalocyanine, into mesoporous silica nanoparticles. The 2,3-
napthalocyanine functions as the photosensitizer in these nanoparticles. These nanoparticles were 
injected into a mouse with a H1299 line orthotopic non-small cell lung cancer tumor xenograft 
[22]. The tumor was irradiated at 50 kVp and 0.2 Gy.  A comparison between the effects of the X-
PDT nanoparticles, X-ray irradiation, and PBS on tumor growth. The nanoparticles were shown 
to be effective at inducing X-PDT, and inhibiting tumor growth as seen in  
These among other PDT and X-PDT nanoparticles and frameworks utilize metals that 
would allow X-ray fluorescence production. These fluorescent X-rays can track the nanoparticles 
within a specimen given enough flux and energy. Additionally, by nature of PDT itself, visible 
light would also be produced and can be used to track these NP’s as well. Thus, a combinatorial 
Figure 1.4: X-ray PDT was conducted using LiGa5O8:Cr nanoparticles within a tumor-bearing 
mouse. (a) The tumor growth was shown to be stunted after X-ray irradiation with the 
nanoparticles in comparison to PBS or X-ray irradiation alone. (b) The X-PDT case showed a 
weaker signal from the tumor than the other cases after 7 days of tumor growth indicating hindered 
growth. (c) The cultures also show less density in the X-PDT case indicating once more a heighten 
level of cell death via X-PDT. Adapted from [22]. 
Image © Royal Society of Chemistry 2017 
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X-ray luminescence and X-ray fluorescence imaging system would be useful and purposeful in 
tracking the position or biodistribution of nanoparticles.  
1.4 A Background on X-ray Fluorescence 
1.4.1 Brief Overview of Medical Based X-ray Fluorescence 
Much of the medical exploration of X-ray fluorescence-based imaging comes from the 
mapping of key naturally occurring trace metals in biological samples. Being able to map these 
metals and their relevant processes in vivo can easily have numerous applications in clinical 
medicine. Such mapping can identify indicative pathologies of metals such as copper or 
magnesium in Parkinson’s disease and other neurodegenerative disorders [23]. More specifically, 
recent research found a lack of copper within the substantia nigra and locus coeruleus in the brains 
of Parkinson’s disease patients [24]. However, many of these studies and investigations are 
conducted using synchrotron radiation, and cannot be practiced in vivo due to dosage concerns. 
Nevertheless, researcher remain hopefully in imaging endogenous and exogenous metals. 
Nanoparticles targeted to specific biological targets to enhance their overall signal and reduce the 
need for an intense synchrotron source. Recent work shows clinical ability of mapping naturally 
occurring trace metals includes the use of fluorescent nanoparticles coupled to ligands to serve as 
biomarkers on DNA [25]. With the growing study of the role of traces metals in genomics and 
proteomics, spatially resolvable maps of the concentration of these trace metals have become 
critical [26]. Currently, X-ray fluorescence computed tomography (XFCT) has generated much 
attention as a potential means for mapping these trace metals since it does not require destructive 
sample preparation like those of SEM EDX, PIXE, and other methods. X-ray fluorescence analysis 
(XRF) has shown to be a viable method to acquire these concentrations of metals and markers of 
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interest, but without providing spatial information.  The amount of information acquired from X-
ray fluorescence can be increased significantly through the means of producing an image as done 
in X-ray Fluorescence Computed Tomography (XFCT), which can provide both spectral and 
spatial data. 
1.5 X-ray Fluorescence Analysis and X-ray Fluorescence Computed Tomography 
1.5.1 Fundamentals of X-ray Fluorescence  
X-ray fluorescence analysis fundamentally depends on the ability for elements to produce 
signature X-rays when they interact with an initial primary X-ray. X-rays, in general, are produced 
from the atomic electron transitions and, therefore, contain characteristics specified by their 
element of origin. The typical stable atomic structure contains electron orbitals with correspond to 
specific distinct energy levels [27].  To remove an electron from its orbit, a certain level of energy, 
or binding energy, must be spent. If the removal of an inner orbital electron occurs through the 
photoelectric effect, an outer orbital electron may jump in to fill this new vacancy. This electron 
transition may produce a characteristic X-ray of energy equal to the difference of the two orbital 
binding energies. X-ray fluorescence occurs when a primary X-ray provides the initial energy 
required to remove an inner orbit electron, with the resulting electron transition producing the 
“secondary” fluorescent X-ray. The probability of the photoelectric effect occurring per atom can 
be expressed as a rough proportionality [28]: 








 As the name might imply, characteristic X-rays’ energies depend on their target material, and 
thus can be useful for identifying the elemental composition of a specimen [28]. The energy of 
these characteristic X-rays depends on two aspects: (1) the inner orbital, in which the photoelectric 
effect has occurred and a vacancy is produced and (2) the outer orbital in which filling electron 
originated from.  
The energy level diagram in Figure 1.5 shows both the various atomic levels as well as the 
additional subshells [29], [30]. The naming convention derives from the transitions within these 
shells. A K X-ray comes from a transition where an outer-shell electron fills a vacancy in the K-
shell. Specifically, a Kα X-ray occurs when the outer shell electron is from the L-shell while a Kβ 
signifies that the outer shell electron is from the M-shell [30]. 
 
Figure 1.5: An Energy Level Diagram depicting the naming convention of characteristic X-rays adapted from [30] . 




XRF utilizes the principle concept that the measured X-ray fluorescence intensity of a peak of 
an element relates to the concentration of the element in a sample [31]. This relation can be 
identified through a calibration procedure, which measures peak values of a known concentration 
of the element to be determined [32]. Many recent studies have successfully used bench-top 
sources to quantify concentrations of lead in bone and gold nanoparticles in small tubes, albeit 
with relatively high concentrations [33], [34].  
1.5.2 XFCT Geometries 
XF analysis techniques can be translated to 3-D imaging by using various combinations of 
collimation, pixelated detectors, rotational motors and translational motors. Traditionally, the 
XFCT modality typically incorporates a X-ray beam to probe a rotating and/or translating sample. 
However, throughout the 1980’s, in order to gain sufficient characteristic X-ray yields, synchrotron 
sources were implemented [35]. They also incorporate known reconstructive techniques such as 
filtered-back projection or iterative reconstruction [35]. 
The majority of initial XFCT studies used a collimated pencil beam along with an 
uncollimated X-ray photoncounting detector placed adjacent to the beamline. The sample is 
translated and rotated followed by a reconstruction techniques similar to a first-generation CT 
system. This is often referred to as a line by line (LBL) acquisition, which permits the acquisition 
of tomographic information of the object through a sequence of projections, which are then 
reconstructed. However, with advancement in the field, cone-beam geometries have also been 
investigated. An example of which is seen in  Figure 1.6. In this geometry the sample is simply 
rotated, the spectral peak for the element of interest is selected and a sinogram is produced [36]. 
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1.5.3 Limitations of XRF and XFCT 
One would expect XFCT would perform well in vivo since X-rays are ubiquitous in the 
hospital setting. However, its in vivo use is also subject to a series of questions, such as the amount 
of contrast agents (e.g. metal nanoparticles) or the excessive dose needed to obtain acceptable 
images [3,4]. A Monte Carlo simulation study suggested that less than 0.5% by weight GNP 
sample with 1 mGy dosage would provide poor image contrast with a current XFCT system 
[37][33]. These are mainly due to the intrinsically low interaction probability of the incident X-
rays with the relatively low concentration of the metal content. Scattering X-rays of the primary 
beam also produce noise, which can hinder overall image quality. Additionally, such simulation 
studies show a limited sensitivity of 1µg/g [38]. Another ex vivo work performed by a group in 
The University of Texas MD Anderson Cancer Center showed gold NP (GNP) concentrations of 
around 0.27% weight (2.7 mg/ml) [36].   
 
Figure 1.6: An example of a system using a conebeam geometry and a collimated photon-counting detector to examine 







 A table of collected studies show a list of acquisition times and experimentally 
demonstrated imaging concentrations from various XFCT studies is seen in Table 1.1. To begin 
seeing biological relevant features for molecular imaging concentrations closer to 10 μg/mL down 
to 10 pg/mL would be considered worthwhile. The current state of the art falls short of these 
sensitivities. 
1.5.4 Addressing the Limitations 
With such limitations, can mapping naturally occurring metals such as copper in mouse 
brain under in vivo settings be feasible, and can one do this with a benchtop X-ray source instead 
of a synchrotron X-ray source? To address this groups have been looking into implementing 
confocal collimation geometries [39], [40] in mimicry of nuclear medicine and emission 
tomography methods. This X-ray fluorescence emission tomography (XFET) approach to XFCT 
uses a pencil beam to irradiate the object line by line while a position-sensitive photon-counting 
detector acquires the fluorescent information.  This work explores this alternative approach that 
relies on mechanical collimation and X-ray detectors to construct specific imaging geometries 
capable of mapping the elemental distribution of these trace metals without the need for full 3-D 
image reconstruction using benchtop X-ray sources. Earlier works by this group have 
demonstrated the plausibility of such imaging techniques without the use of computational image 
Element of 
Interest 
Work 1 Work 2 Work 3 Work 4 Work 5 














Gd 20 mg/ml 
(2% wt)[66] 
20 mg/ml 
(2% wt) [63] 
10 mg/ml 
(1% wt) [80] 
  
Pt 5 mg/ml 
(.5% wt)[63] 
    




reconstruction techniques using synchrotron radiation from the Advance Photon Source [40]. By 
designing the aperture with a large open fraction (say 10% or more), one just needs to count how 
many fluorescence X-rays pass through the aperture, which will directly provide the elemental 
concentration values. Therefore, the metal concentration derived in this way is free of the so-called 
decoding penalty associated with 3-D imaging reconstruction, and could potentially have reduced 
statistical noise. By using high sensitivity imaging detectors and apertures with large open 
fractions, this approach would have the potential of offering the optimum sensitivity for 
quantifying the metal concentrations in 3-D samples.   
Attenuation correction for this imaging method would also be necessary for both the 
incoming incident X-ray irradiation and the subsequent fluorescence. Without such correction, a 
reduction in image contrast of deeper features in the sample would be observed [37][41]. This 
attenuation correction can be estimated by using CT information or other a priori knowledge [41]. 
Several benchtop studies in the past decade have shown promise in the ability of XFCT in terms 
of sensitivity and resolution [32], [33], [42], [43]. A previous study has already demonstrated that 
XFCT can be more sensitive than conventional CT for a given dose [33]. However, further work 
needs to be done to reduce acquisition time while maintaining or improving the sensitive to see 
use in vivo. 
1.6 A Background on X-ray Luminescence 
1.6.1 Potential Medical Applications for X-ray Luminescence 
Quite similar to X-ray fluorescence, the rise of X-ray luminescence came from the need to 
combine the anatomical information of CT with information of the molecular processes that 
underlie various diseases. However, unlike X-ray fluorescence, X-ray luminescence requires the 
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use of nanophosphors, scintillators, or the like to produce the visible light being imaged. XL has 
not been demonstrated to image endogenous processes or molecules.  
1.6.2 An Overview of X-ray Luminescence and X-ray Luminescence Computed Tomography 
X-ray luminescence depends upon the process known as scintillation, in which X-rays are 
converted into visible light. These X-rays deposit energy into a target material causing the release 
of secondary electrons. The released high energy electrons cause further ionization downstream 
which ultimately results in the production of a large amount of low energy electrons. If the target 
is not a scintillator, the energy of these electrons emits into heat. In scintillators, the electrons 
excite ion dopants into a temporarily stable excited electronic state. When this excited state returns 
back to ground, optical photons are released [10]. 
More specifically, within a solid-state crystal or phosphor, X-ray photons can deposit a portion 
up to all their energy to electrons through photoelectric or Compton interactions. Through various 
interactions, these electrons lose their energy and tracks of excited electrons are produced. Once 
these excited electrons are reduced to an energy of about two to three times the band gap of the 
dopant, they can migrate to the luminescent center of the crystal, recombine with holes, and 
produce light [44]. These X-ray luminescent photons typically have yields far greater than one; as 
another work established, a 100 keV photon interacting with a specific gadolinium oxysulfide: 
terbium phosphor could produce an average of 6000 photons [44], [45]. The emitted light typically 
falls within certain ranges of wavelengths depending on the phosphor; thus, certain nanophosphors 
or scintillators may emit green light while others could emit red. This allows for the targeting and 
separation of differing nanophosphors injected into the body. The energy level of these 
luminescent centers are what determine the wavelength of the emitted photons, whether it be in 
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the IR, NIR, or optical range [46]. Typically, decay times for these excited states are in the range 
of 30 to 500 nanoseconds [46]. Other processes can compete with the luminescent process such as 
phosphorescence, which occurs when a secondary electron is trapped in the luminescence center 
and requires additional energy to decay to the ground state. These additional energy often comes 
from thermal excitation [47]. This phosphorescence process can cause a delay in visible light 
production and produce an effect called “after-glow”.      
Combining this process with typical tomographic methods creates what is known as XLCT.  
In XLCT, a sample is irradiated by a pencil-collimated X-ray beams as it translates or rotates at 
set intervals in a geometry similar to that of first generation X-ray CT [10]. This is setup is shown 
in Figure 1.5. The nanophosphors are excited within a given irradiated volume emit visible light 
photons that are detected by an optical camera placed perpendicular to the incident pencil beam. 
The measured flux of these photons is proportional to the amount of nanoparticles in the irradiated 
beam path. Since one knows that the optical signal comes from the known beam path, the optical 
detectors do not require spatial resolving ability [48]. Various rotations and translations of both 
the motor and sample can ultimately produce a sinogram similar to that of conventional CT. 
Typical CT reconstruction techniques can then be applied to produce an image of 
nanophosphorous volume. 
1.6.3 Limitations of X-ray Luminescence Computed Tomography 
Many of the limitations of XLCT are akin to those of XFCT. Most current methodologies 
of image acquisition can be considered quite long for X-ray exposure. Additionally, since XLCT 
relies on probabilities of X-ray interaction with the nanophosphors and the probability of light 
emission. Only large concentrations (0.2 mg/mL to 1 mg/mL) of nanoparticles/nanophosphors 
have been used in demonstrations of XLCT [49]. While some studies suggest that current XLCT 
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systems can capably perform in vivo studies, current experimentally verified doses of nanoparticles 
are deemed impractical for such studies [50]. However, simulation studies have indicated the 
feasibility of XLCT at depth in mouse-sized subjects, with nanophosphors concentration of the 
order μg/mL with doses between 1 to 10 cGy [51]. 
Compare to XFCT, however, XLCT produces many more emission photons. At most, only 
one X-ray fluorescent photon can be produced by an incident X-ray photon while several optical 
photons can be emitted in XLCT. However, XFCT emits higher energy X-ray which can penetrate 
at greater depths that optical photons. Thus the main dilemma of XLCT resides in the scattering 
and diffusion of optical photons posing problems in both sensitivity and resolution [49], [52]. 
Scattered X-ray photons can excite scintillator materials outside of the beam path causes a loss in 
resolution; additionally, scattered optical photons can either reduce sensitivity or produce an image 
blur reducing image contrast and introducing noise [10]. 
Additionally, endogenous phosphors, such as (water, hemoglobin, and aromatic amino 
acids), can produce their own luminescence during X-ray excitation, and, therefore, produce noise 
in the image. Tissue and blood can also absorb or scatter NIR and optical photons quite well, 




1.6.4 Addressing the Limitations  
Address the dosage and long acquisition time for these systems can be accomplished 
through a combination of methodologies. For instance, a large effort has started in examining 
reconstruction methods for the derivation of internal radioluminescence sources in the target 
[10], [48], [52], [53]. Additionally, a priori knowledge through CT or MRI can possible give 
information vital to determining attenuative information of the subject.  Other attempts at 
improvement include using multiple detectors to reduce acquisition time, or simply limiting the 
usage to shallower depths. Lastly, our own collaborative work has considered combining 
reconstruction from XFCT (for resolution and depth information) with the sensitivity of XLCT. 
Figure 1.7—A first generation XLCT setup with a geometry similar to that of first generation X-ray CT  [48]. 




1.7 The Competing Modalities for XFCT and XLCT  
XLCT is in the realm of molecular imaging. The most clinically available molecular 
imaging tools would be Positron Emission Tomography (PET) and Single Photon Emission 
Computed Tomography (SPECT). Both these modalities require the use of radiopharmaceuticals 
that emit high energy gamma rays. These radiotracers accumulate in the specific regions of the 
body to monitor various biological processes such as glucose uptake. The high energy gamma rays 
can penetrate tens of centimeters of tissue, which is useful for whole body imaging [54]. These 
modalities also have high sensitivity and specificity, but have poor spatial resolution in the realm 
of millimeters when compared XFCT and XLCT [10]. XFCT, for instance, has shown a spatial 
resolution of around 100 μm [55]. However, the sensitivity for XFCT and XLCT have only 
demonstrated sensitivities in nmol/mL while SPECT and PET have sensitivities of pmol/mL. 
The resolution of PET is limited by the finite positron range and non-collinearity issues of 
annihilation photons degrading its overall spatial resolution [28]. SPECT suffers from a trade-off 
of geometric sensitivity and resolution depending on its collimation size [28]. Additionally, the 
radiotracers for both PET and SPECT are non-activatable. XFCT and XLCT have the advantage 
that the tracers and/or therapeutic agents are activatable by an external X-ray source, which limits 
radiation dose only to a specific region and reduces noise contribution due to the diffusion of the 
radiotracer.  
Another optical imaging modality known as optical fluorescence imaging is another 
mainstream method for preclinical imaging. Fluorescence imaging utilizes optically fluorescent 
dyes that are taken up by cells. These modalities include Diffuse Optical Tomography (DOT), 
Optical Coherence Tomography (OCT), Bioluminescence Optical Tomography as well as a 
plethora of others. These modalities have a great advantage of high molecular specificity for these 
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optical probes and great spatial resolution at superficial depths [10], [56]. However, XLCT in 
comparison to this modality has greater spatial resolution at imaging depths. Optical fluorescence 
imaging is limited by the scattering of emitted optical light at these greater depths [10].  
Magnetic Resonance Spectroscopy (MRS) competes with X-ray fluorescence-based 
spectral analysis in their ability to quantize trace metals in a sample. MRS uses high strength 
magnetic fields in conjunction with a RF pulse at a specified frequency to examine particular in a 
region of interest [11], [12]. Although magnetic resonance based imaging and spectroscopy are 
pervasive for in vivo use, they suffer from intrinsically low sensitivity with SNR value of 3:1. 
This significantly low SNR is magnitudes less in order than fluorescence-based imaging and 
mass spectrometry [57].  
Mass spectroscopy also has the capability to identify the chemical composition of trace 
elements in a sample. Mass spectrometry measures the mass-charge ratio to determine the 
presence of certain nuclei. However, mass spectrometry requires the use of vacuums and sample 
preparation, which often results in sample destruction. This makes mass spectrometry non-ideal 
for in vivo application [26], [58], [59]. 
A composite table expanded from a review work by Moiz et al provides a comparison of 
the advantages and disadvantages of XLCT and XFCT to other modalities [10], [60]. XFCT and 
XLCT have the advantage of activatable probes but lack sensitivity and temporal resolution 
compare to other modalities. They are also not as cost-effective as CT or optical, but cheaper 



















XFCT +++ +++ ++ ++ Yes $$$ 
XLCT +++ ++ ++ +++ Yes $$$ 
PET + ++++ ++++ +++ Limited $$$$ 
SPECT + ++++ ++++ ++ Limited $$$$ 
MRI ++++ ++++ + + Limited $$$ 
CT ++++ ++++ + ++ Limited $$ 
Optical ++++ + +++ ++++ Yes $ 
 
Table 1.2: A table comparing various molecular imaging modalities. 
Modified and expanded from  [10] © 2014 IEEE. 
 





 : PROOF OF CONCEPT OF A TRI-MODAL XF/XL/CT 
SYSTEM 
2.1 Abstract  
The initial objective is to design a single system that can conduct X-ray luminescence 
computed tomography, X-ray fluorescence computed tomography, and X-ray transmission 
computed tomography image. The system was designed with the capacity to switch between 
different imaging geometries that detect XF and XL signals within a small gel phantom.  The work 
successfully demonstrates the capacity to image at sub-500 μm resolution 3D images of XLCT 
and XFCT for both geometries. However, concentrations and imaging time for these images were 
quite high, and in future works, these need to be reduced in order to achieve in vivo imaging.  
2.2  Introduction  
The advent of nanoparticle (NP) therapy has pushed researchers to explore new ways to 
monitor their circulation in the body as well as their therapeutic efficaciousness. One such 
treatment method, X-ray-activated photodynamic therapy (X-PDT), shows promise in its ability 
to deposit therapeutic effects at greater depths than possible with traditional photodynamic therapy 
[11], [12]. The process that produces the therapeutic effects could also potentially generate X-ray 
fluorescence and/or X-ray luminescence, which provides the means to monitor the distribution of 
the NPs and their therapeutic activation respectively. Additionally, the use of X-rays implicitly 
allows for the potential of X-ray Compton Scattering (XS) to provide information on electron 
density and incident beam attenuation while conventional CT can give anatomical information. 
This gives room to the possibility of using a quad-modality X-ray fluorescence (XFCT), X-ray 
luminescence (XLCT), XS, and CT system for monitoring X-PDT NPs.   
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 This work experimentally investigates the ability of a XFCT/XLCT/CT quad-modality 
imaging system for monitoring X-PDT NP’s, such as Y2O3:Eu3+, through the use of a geometry, 
which mimics that of the X-ray microbeam therapy environment. In such an environment, the 
intense highly collimated incident X-ray beam would produce the fluorescent and luminescent 
yields needed for XFCT and XLCT imaging.  This work will specifically provide 3D tri-modal 
images of a phantom containing X-PDT-containing agents. 
2.3 Materials and Methods 
Two different system geometries are used to produce either a pinhole geometry on the 
detectors with a sheet beam irradiating the sample or slits on the detectors with a pencil beam 
irradiating the sample.  
2.3.1 An Overview of the System 
The system is comprised of four detectors and two sources arranged in two different planes 
as seen in Figure 2.1. The first source is an Oxford Instrument Apogee-5500 microfocus 
polychromatic X-ray source with a tungsten target that can ramp up to 50 kVp and 1 mA.  This 
source is located on a plane above the second source. The second source is a monochromatic 
Xenocs Genix with a Mo target that emits 17.4 keV X-rays. The Xenocs source can emit 25x106 
photons per second in a 146 μm FWHM area. A precise overview of the dimensions for the 
geometry is seen in Figure 2.2. 
The first detector, the Andor DO-936 Charge-Coupled Device (CCD), was arranged 
perpendicularly to the beamline to obtain X-ray fluorescence. The Andor DO-936 has 2048 by 
2048 square pixels with 13.5 μm pixel pitch. For the pencil beam geometry, the CCD was coupled 
to a three-slit aperture with each of 100 micron slit width as seen in Figure 2.3. In the sheet beam 
geometry, the CCD was coupled with a 300 μm pinhole.  The CCD camera provides excellent 
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spatial resolution with the small pixel size, and excellent energy resolution (3% at 8 keV). 
However, the quantum efficiency drops from 14% at 10 keV to ~1% at 20 keV. 
An electron-multiplying CCD (EMCCD), Andor iXon 887, coupled with a demagnifying tube 
(DM tube) was also positioned perpendicular to the beamline, but across from the CCD.  The 
EMCCD has 512 by 512 16 μm square pixels while the DM tube demagnifies a projection on its 
surface to .25 of its original size. The DM tube also has a Nikon Lens attached to it. The DM tube 
reduce spatial resolution, but increases both the geometry solid angle and the efficiency of the 
detector. This potentially allows for detection of single photons over background noise.   
Additionally, two detectors, the Andor Zyla and the Amptek XR-100T, are attached to two 
linear motors across from the beamline. The motors allow for the detectors to move vertically as 
well as perpendicularly to the beamline. The Andor Zyla camera has contains 2560 by 2160 square 
pixels of 6.5 μm pitch, and is coupled to a CsI scintillator to convert incoming X-rays to visible 
light for the CMOS camera to detect. The small pixel size allows for high spatial resolution, which 
would allow for high resolution CT in future applications. However, the CsI scintillator reduces 
the spatial resolution due to light spread before detection. A 10𝜇𝜇m FWHM pencil beam would 
appear as a 60 𝜇𝜇m projection FWHM on the detector.  However, for the scope of this work, the 
resolution is more than adequate, but as we wish to expand into in vivo biodistribution imaging, 
the ability to examine features such as vasculature can prove useful. 
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The Amptek XR-100T is a single pixel CdTe detector of 1 mm thickness and 5 mm by 5 mm 
pitch. The CdTe detector has ~100% photoelectric absorption from 5 keV to 100 keV [61]. Since 
the setup is predominantly used for low energy X-ray imaging, the Amptek CdTe detector proves 
ideal for our purposes. The Amptek detector can be used to acquire spectra of the incident beam 
or of the incident XF. In later studies, the detector is used to roughly estimate the dosage applied 
to the sample. 
Figure 2.1: Both the Andor EMCCD and CCD are arranged perpendicular to the beamline to collect X-ray 
fluorescence and X-ray luminescence respectively.  The Andor Zyla lies across the system and has a CsI 
scintillator attached to its surface to convert incoming X-rays to visible light. 
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Additionally, the sample is held together by a series of motors from both Newport and 
Velmex. The Velmex motors translate the sample vertically and towards or away from the X-ray 
sources. This is used to adjust the magnification ratio for CT imaging, as well as aligning the 
sample into the FOV of the EMCCD and CCD. The Velmex motors have an accuracy of 
approximately 38 μm for every 250 mm of travel. The Newport motor is used to translate the 
sample perpendicularly to the beam for scanning. The Newport MFA-CC has 25 mm range and a 
guaranteed accuracy of ± 3 μm.  
Lastly, a large drywall box was used to enclose the entire system. The box is used to shield 
X-rays from the sources from affecting nearby personnel, and also to prevent light photons from 
interfering with the XLCT system. The inside walls of the box were draped with black construction 
paper to assist in absorbing any external signals or scattered light from the sample itself.  
 
Figure 2.2: The figure shows the precise layout of the XFCT/XLCT system. The XFCT/XLCT system 




2.3.2 Experimental Design 
Two phantoms were used in this study. The first is a silica based gel phantom used for the 
pencil beam experiment. The phantom had a 6 mm diameter with 500 micron channels filled with 
Y2O3:Eu2+ NP’s arranged in a triangle as seen in Figure 2.4. The NP’s are capable of producing 
X-ray luminesce. 
The gel phantom was positioned in the monochromatic beamline with the FWHM of the 
beam at the position of the sample to be around 154 μm.  The sample is scanned in both directions 
perpendicular to a 17.4 keV monochromatic beam with 200 μm step sizes over an 8 mm × 1 cm × 
5 mm volume. A CCD collects both the XF and XRS signal with 20 seconds per step for a total of 
7 hours. An intensified EMCCD collects the XL signal with .5 seconds per step for a total imaging 
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time of 8 minutes [62]. The XT CT images are collected in conventional cone-beam CT geometry 
using a Zyla CMOS camera.  
The second phantom is a ABS plastic mouse phantom used for the sheet beam geometry 
experiment as seen Figure 2.5 The phantom has a double layer NMR tube superficially attached 
with the outer tube having an outer diameter of 5 mm and an inner diameter of 4 mm and an inner 
Figure 2.5: A plastic ABS mouse phantom with a 
double tube attached superficially. The tube 
contains yttrium NP’s in the inner layer and NaBR 
in the outer layer. 
Figure 2.4: A silica gel phantom with three 
500 micron channels filled with 
Y2O3:Eu3+NP’s. 
Figure 2.3 A 3 slit aperture made of Mo was 
constructed and attached to the CCD to provide 
positional information for XF. 
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tube with an outer diameter of 3 mm and inner diameter of 2mm. The inner tube contains Y2O-
3:Eu3+ nanoparticles capable of producing XF and XL signals, and can be used for X-PDT. The 
outer layer contains NaBR at a concentration of 172.6 mg/mL.  
A sheet beam was produced by collimating the polychromatic beam with a slit of 
approximately 150 μm width. At the sample location, the beam spread was approximately 212 μm, 
and the plane of the sheet beam was perpendicular to  EMCCD and CCD detector surface. The 
sample is scanned in the direction perpendicular to a polychromatic sheet beam plane with 250 μm 
step sizes over a 1 cm × 1 cm × 1 cm volume. A CCD collected both the XF and XRS signal with 
12 minutes per step for a total of 12 hours. An intensified EMCCD collects the XL signal with 12 
seconds per step for a total imaging time of 8 minutes.  
2.3.3 Image Mapping 
Images from the CCD are produced by mapping as opposed to any computational or 
algorithmic reconstruction method.  The sample is scanned in step sizes determined by the beam 
width. The slit determines the field of view of the CCD. The system geometry’s use of a pencil 
beam and slit restricts the fluorescence to a single line segment at a time. Thus, if the sample is 
scanned in steps perpendicular to the beam a 3D image can be formed as seen in Figure 2.6.  For 
the sheet beam/pinhole aperture, in image is acquired slice at a time as seen in Figure 2.7. It is 
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important to note that the CCD detector is photon-counting so during the image mapping process, 
only photons that fall within the energy range of interest are included in the image.  
Figure 2.6 : (A) During imaging, a linear segment of the ROI can be obtained by summing down the columns of 
the pixels of the projection as seen above. (B) Translating the sample via motors and then interrogating the new 
section and summing down the detectors column would produce a new line segment. When pieced together, these 
segments compose a 2D image or “slice” of the sample (C). 
Figure 2.7 : (A) A polychromatic sheet beam irradiates the sample in this geometry. A pinhole aperture 
is attached to the CCD or EMCCD. Each projection on the camera is equivalent to a slice of the sample. 
Translating the sample in the direction perpendicular to the beam and mapping the resulting summed lines 
produces a 3D image. 
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2.3.4 Producing a Spectra with the CCD 
When using a pixelated detector like the CCD, charge sharing often occurs. Charge sharing 
occurs when an incident photon deposits in energy into multiple pixels.  This can cause a loss of 




Figure 2.8 – (A) The uncorrected scatter plot of summed energy vs the ratio of peak Energy/Summed Energy for the 
Cu Kα1 peak.  The scatter plot was divided into different bins for various ratios. A Gaussian fit was applied for each 
bin with the bins peak shown in red and the standard deviation in green. Aligning the peaks by multiplying each bin’s 
summed energy value by a  correction factor produces (B). Histogramming the summed energy data produced (C), in 
which we see the low energy tailing being corrected. 
 






















processed through a photoncounting code. The pedestal value is subtracted from each frame, and 
events above a lower threshold are located. For each event, a 3x3 region is examined, the highest 
energy in the 3x3 pixel region is considered the peak location of the event, and the surrounding 
pixels are added together to compensate for charge sharing. This is corrected by creating a scatter 
plot of the summed energy of each event against the peak energy divided by the summed energy 
as seen in Figure 2.8A. The scatter plot is divided into bins based on the peak/summed ratio. All 
the events in each bin are fitted with a Gaussian and the Gaussians peaks (red) are lined up together 
by multiplying the events in each bin by a correction factor as seen in Figure 2.8B. The corrected 
spectrum from (C) shows that low energy tailing is corrected through this method. 
2.4 Results 
From the pencil beam geometry, a spectrum and multiple images were obtained. Figure 
2.9A has a spectrum showing the scattered monochromatic beam as well as the Kα1 fluorescence. 
Figure 2.9B shows the XF image with the Kα1 peak. A XRS slice with the energy selected for the 
overlapping XRS signal and Kβ1 peak is seen Figure 2.9C, and the XL slice of the NPs in Figure 
2.9D.  Lastly, a combinatorial image of XF Kα1 (green), XF Kβ1/scattering (red), and XL image 
(blue) is seen in Figure 2.9E. These images indicate that the system does indeed have the potential 
to image yttrium NPs within a small sample. Future work on these set of experiments include 
examining the limits of detection as well as attempting a similar measurement with a light 
scattering medium as the sample. 
 From the sheet beam geometry, another set of images were also obtained. Figure 2.10A 
shows the spectrum obtained from a single slice acquisition. The tungsten peaks (blue) come from 
the X-ray source scattering off the sample and the bromide peaks are highlighted in red. The 
yttrium peaks 14.96 keV Kα1 and the 16.74 keV Kβ1 are also well observed in this spectrum. Figure 
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2.10B shows a multiplexed single slice image of yttrium (green), bromide (red), and the glass (blue 
and derived from scattering of tungsten peaks). Figure 2.10C depicts a combined 3D image 
following the same color scheme of that seen in Figure 2.10B. Figure 2.10D shows a combined 
slice of XL signals coming from the Y2O3:Eu3+ (blue) and the XF signal from bromide (red). 
Figure 2.10E shows the 3D rendering of the XL signal in blue. Figure 2.10F shows a combined 
XFCT/XLCT/CT imaging of the sample with the greyscale showing the CT image, red shows the 
XL from Y2O3:Eu3+, and XF from the bromide.            
 
 
Figure 2.9: All three of these images are of the yttrium filled channels overlayed with a gray CT image of the gel 
phantom. (A) This is an image produced by mapping  Kα1 events only. (B) The red depicts where events from Kβ1 






2.5 Discussion and Conclusion 
 The studies show comprehensively that a combined XFCT/XLCT/CT system is indeed 
possible and that valuable information can be obtained from this system. However, the pencil 
beam experiment utilized Y2O3:Eu3+ powders to achieve the depicted results. Likewise, the sheet 
beam experiment, utilized incredibly high concentrations to achieve the imaging results seen. 
Figure 2.10: (A) The spectrum shows the fluorescence produced by the yttrium peak and NaBr. The tungsten 
peaks produced by the X-ray tube and scattered from the sample are also visible in this spectrum. (B) Shows a 
slice XF image of the yttrium (green), bromide (red), and tungsten selected energies in a single image. (C) Shows 
a 3D rendering of the volumetric data following the same color scheme of that seen in the slice image. (D) Shows 
a slice with the bromide fluorescence in red with the Y2O3:Eu3+ luminescence in blue. (E) Figure E shows just the 
volumetric luminescence in blue. (F) The image shows a 3D multimodal image with the Br fluorescence in blue, 




 Following studies would need to be conducted to better understand the sensitivity of the 
system. This includes examining the detection limits for both XFCT and XLCT. Additionally, a 
comparison can be down between the two imaging geometries. For a given resolution and SNR, 
the dose needed to acquire acceptable images for each of the two geometries should also be 
examined and compared. Nevertheless, the study performed its function of demonstrating a 
















 : A SIMULATION AND ANALYTICS EXAMINATION OF A 
SIMPLE XFCT IMAGING SYSTEM.  
3.1 Abstract 
As a continuation of earlier, this work uses a mix of Monte Carlo simulation in combination 
with analytical calculation to determine the minimum detectable concentration of platinum in a 
simple X-ray Fluorescence Computed Tomography system. The work examines the dosage and 
time needed to achieve an SNR of 3 for various platinum concentrations and detector resolutions. 
A simple geometry using a pencil beam to irradiate a water phantom containing Pt, and a single 
slit coupled to a CdTe detector to collect the resulting fluorescence.  
3.2 Introduction 
X-ray fluorescence computed tomography (XFCT), has emerged as promising modality 
combining X-ray analysis and tomography for examining elements within a sample in a non-
destructive manner [33], [42], [63], [64]. Typically, XFCT began using a synchrotron source and 
scanning and rotating the sample. Synchrotron radiation produces a high flux monochromatic 
beam that provided a fluorescent spectrum of high SNR. However, synchrotron radiation proved 
unsuitable for biomedical in vivo studies due to its high dose, scan times, expensiveness, and lack 
of accessibility [32], [65].  
To improve the system, researchers have replaced the synchrotron source with 
polychromatic X-ray tubes and both experimental work and simulated work demonstrated 
benchtop XFCT systems with reduced dosage and scan times [42], [66], [67]. However, imageable 
concentrations and resolutions have yet to be reach for in vivo imaging.    
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Within the field of XFCT, cisplatin and gold nanoparticles (GNPs) have garnered much 
attention for their anti-tumor efficacy [68], [69]. Gold nanoparticles can reach the target tumor site 
through both passive, through the enhanced permeability and retention effect, and active targeting. 
The GNPs can then produce a cytotoxic effect through thermal ablation, photodynamic therapy, 
auger electron production as well as other means [68]–[72].  Cisplatin, likewise, has been shown 
to be anti-tumor by disrupting DNA replication [73]. 
This work uses GEANT4 Monte Carlo simulation combined with some analytics to 
determine what dosage, time, and resolution could be achieved to image a mouse sized phantom 
with biologically relevant in vivo concentrations.  
3.3 Materials and Methods 
In order to calculate the detection limits of the XFCT system, a mix of GEANT4 Monte 
Carlo simulation is conducted using a simplified geometry seen in Figure 3.1. The simulation uses 
Figure 3.1: The geometry used for the XFCT simulation.  The detector is 1 cm or 5 mm away from the slit aperture. 
The slit width is variable and the aperture’s thickness is .2 mm with an infinite density. The detector is 1 mm thick 
and composed of CdTe. The pencil beam has a .75 mm diameter.  Within the water phantom is a 1 mm diameter 
region containing phantom. 
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an emission based geometry referred to as X-ray Fluorescence Emission Tomography. The 
simulation uses one slit of variable widths of 0.125 mm, 0.250 mm, 0.500 mm, and 1 mm coupled 
to a 1 mm thick CdTe detector of 20 mm width and height. The detector was comprised of 250 μm 
square pixels forming an 80 by 80 array. The slit is .2 mm thick and simulated as infinitely dense 
aluminum. Two detector-to-slit-distances of 5 mm and 1 cm were also tested for each of the slit 
widths. The slit-to-sample-distance is 1 cm. The sample is a 1.5 cm water phantom of 2 cm height. 
The water phantom contains a 1 mm diameter region containing the platinum.  
The X-ray source is a pencil beam of 0.750 mm in diameter. The source spectrum comes 
from a commercial company called Excillum. The spectrum comes for a Metaljet source using a 
liquid Gallium-Indium alloy as the target and running at 250 W and 160 kVp.  The spectrum for 
this source can be seen in Figure 3.2. The units are a normalized form of counts considered A.U. 
Figure 3.2: The incident energy spectrum is depicted here. The units are arbitrary units, but the 
overall profile is maintained in this figure. The source uses a GaI alloy target as the anode 
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as the initial unfiltered spectrum was given under the agreement of confidentiality. The source was 
positioned 10 cm away from the sample and thus, a solid angle must be considered when 
determining overall beam flux.  
3.3.1 Signal Production 
After determining the geometry and initial beam spectrum, one needs to calculate the signal 
by determining the fluorescent photons reaching the detector. This is done through two different 
methods. The first utilizes an analytical means while the second utilizes the Monte Carlo 
Simulation. 
Analytical Methodology for Signal Calculation 
 The analytical methodology first takes the initial X-ray spectrum and calculates the 
attenuation the beam will face traveling through the water phantom. The total attenuation cross 
section of water can be obtained from the National Institutes Standards and Technology’s XCOM 
database [74]. The average path length for the incident beam through the sample can be calculated 
from the geometry and was determined to be 6.45 mm. Equation 3.1 shows how the resulting 
spectrum can be calculated. N(E) is the counts of the incident X-ray beam after being attenuated 
by water for a given energy E. No is the unattenuated counts for each energy bin E of each channel. 
𝜇𝜇at is the total attenuation coefficient for a given energy E, and t is the path length, t, which has a 





Equation 3.1: An equation that calculates the incident photons that reach the platinum region. 
𝑁𝑁(𝐸𝐸) = 𝑁𝑁𝑜𝑜(𝐸𝐸)exp(−𝜇𝜇𝐴𝐴𝐴𝐴𝐴𝐴(𝐸𝐸) ∗ 𝑐𝑐) 
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The resulting spectrum is shown in Figure 3.3 and arbitrarily scaled to maintain confidentiality of 
Excillum’s spectrum.  
From here, the number of photons undergoing photoelectric absorption per second was 
calculated using Equation 3.2.  S(E) is the number of fluorescent photons produced from incident 
photons of energy, E. N(E) is the number of incident photons after being attenuated by the water 
phantom and reaching the platinum region of the sample.  σPE is the photoelectric cross-section of 
platinum for energy, E, of the incident spectrum, which was obtained from XCOM [74],   𝜌𝜌 is the 
Figure 3.3: The spectrum shows the profile after attenuation by water. The y-scale is arbitrarily given, 
but the profile is maintained.   
Equation 3.2: An equation that calculates the number of fluorescent photons produced from 
the sample. 
𝑆𝑆(𝐸𝐸) = 𝑁𝑁(𝐸𝐸) ∗ (1 − exp(−σPE(𝐸𝐸)𝜌𝜌𝑐𝑐)) 
42 
 
concentration of platinum in the cisplatin defined region of the water phantom, this value can range 
from 10 mg/mL to 10-7 mg/mL t is the path length of the incident photons through the cisplatin 
region of the water phantom; t is equal to 1 mm in this case. This produces a spectrum seen in 
Figure 3.4. 
 After the fluorescent photon production is calculated, we next determine how many 
photons reach the detector per second and the overall signal rate. The signal rate, S’ (in units of 
photons/s), is given through  Equation 3.3.  S(E) is the number of photons that undergo the 
Figure 3.4: The spectrum shows the profile after attenuation by water. The y-scale is arbitrarily given, 
but the profile is maintained.   
Equation 3.3: An equation that calculates the total number of fluorescence that reaches the 
detector. 







photoelectric absorption by platinum per second.  The model assumes that all photoelectric 
absorption yields characteristic X-rays and that photoelectric absorption is the primary means of 
fluorescent production. 𝜑𝜑 is the solid angle between the sample and the detector (going through 
the slit). 𝜑𝜑 is the solid angle factor for the incident beam’s flux unto the sample. The spectrum 
provided by Excillum is in terms of brilliance, and therefore, solid angle of the beam needs to be 
calculated to determine flux. 𝜑𝜑 is the percent yield expected to occur for the Kα1 line of platinum, 
which is 66.8 keV. Lastly, ∅ is a factor that calculates the portion of Kα1 fluorescent photons that 
exit through the sample unattenuated (93.5%).   This formula results in the signal obtained by the 
detector.  
Monte Carlo for Signal Calculation 
 To verify the signal calculation, a Monte Carlo simulation was performed setting the 
concentration of platinum at 10 mg/mL.  Trying to run simulations for nanogram or microgram 
levels were deemed time and computationally intensive for achieving significant fluorescent 
counts, so the signal level was then assumed to decrease linearly with the decrease in 
concentration. The results of signal production from the simulation versus the analytical 
calculation showed that the analytical model produced 8.34% signal over the Monte Carlo value 
at 10 mg/mL Pt. The effects are beam-hardening (which are not accounted for in the analytical 




3.3.2 Noise Production 
The noise production was determined from the scattering of the incident beam that landed 
within the detector. The Monte Carlo simulation provided this noise production rate, and a 
resulting spectrum is seen for 10 million events in Figure 3.5A. From the spectrum, events that 
fall within 1 keV of the 66.8 keV Kα1 peak of platinum were selected and their profiles plot as seen 
in  Figure 3.5B. The region of the detector that coincides with the fluorescence profile from the 
sample is selected, which can vary with the size of the ap erture. The number of scattered photons 
Figure 3.5 (A) The scattering of the incident spectrum unto the 
detector. (B) The figure shows the profile of all photons within 1 





that fall within both the specific energy window and spatial window per second is considered the 
noise rate.  
3.3.3 SNR calculation 
The SNR is calculated using the formula seen in Equation 3.4, where S is the derived 
signal rate in counts per second, t is the time in seconds, and N is the noise rate in counts per 
second.  
 
The time to obtain an SNR of 3 can be calculated by solving for t. The signal rate will depend on 
the aperture width as well as the concentration of platinum, while the noise essentially only 
depends on the aperture width. The dose rate is determined from the GEANT4 simulation, and is 
used as a constant rate over time, meaning dose and time are directly proportional. Resolution is 
determined as the distance for two point sources to have non-overlapping projections on the 
detector. 
3.4 Results 
Using the earlier described methods, the time and dosage needed to image at various 
resolutions is depicted in Figure 3.7 and Figure 3.6.  The result of the Monte Carlo simulation for 
signal calculation produced results comparable to the ones analytically derived as seen in Figure 
3.8. 








As points of comparison, the 5-mm slit-to-detector geometry, was able to detect 22 μg/mL 
in 3 minutes using 1.9 μGy while the 1 cm slit to detector geometry required a 2.35 μGy dose and 
3.7 minutes using the 1 mm wide slit. The simulation for the 1 mm slit width and 5 mm slit-to-
detector geometry required 2.17 μGy and 3.4 minutes. Another point of interest, with the 1 mm 
slit and 5 mm slit-to-detector geometry, to image 1 μg/mL of platinum would take 0.92 Gy while 






Figure 3.6: The figure above depicts the sensitivity curves for detecting platinum at various slit widths. 
The figure here depicts a 1 cm slit to detector distance and a 1 cm slit to sample distance.  
Figure 3.7: The figure above depicts the sensitivity curves for detecting platinum at various slit 




Figure 3.8: The analytical method for source calculation (top) is compared to the simulated method (bottom). The 




3.5 Discussion and Conclusions 
The results showed that the Monte Carlo model and the analytical model for calculating 
the signal production and ultimately SNR for the system matched very well. The calculation of 
SNR in both these methods show that imaging and/or quantifying concentrations of tens of μg/mL 
can be achieved reasonably well at tolerable resolutions, dosages and times. However, as the signal 
decreases and the noise becomes the dominant factor in the SNR calculation. Achieving 1 μg/mL 
or even less with a single slit system would be intolerable for in vivo imaging. However, this can 
be address through an increase in the geometry efficiency of the system, the majority of the 
detector space is unused with a single slit, and thus multiple slits can be added to increase the 
geometric efficiency. Additionally, a ring of detectors can also be added to the system to increase 
the geometric efficiency as well. Assuming a linearly proportional relationship, a 10 ring and 10 
slit detector system would therefore reduce the time and dosage need to acquire 100 ng/mL down 
to .92 Gy or higher concentrations can be imaged at significantly faster speeds.  
A large reason why the following system works reasonably well is due to the choice of 
incident X-ray spectrum. The non-signal contributing energies are filtered out, and the tungsten 
peaks that are produced by the vast majority of polychromatic tubes do not occur from the GaI 
target. The tungsten characteristic peaks (specifically Kβ) significantly overlap with the Pt Kα1 
peaks, which produce a lot of noise for both simulation and experimental purposes. Aside from 
the experimental use of a full ring system, investigations can be to optimized the incident spectrum 
to reduce the noise component (which determines when the sensitivity curve starts flattening) and 
increase the signal/fluorescent production. A final compromise for this work would be to develop 
a non-imaging system that is capable of quantifying fluorescent signal from a specified region. In 
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this case, the slit pencil geometry still limits the FOV to a select region of interest. However, 
instead of providing an image of the region. The slits can be designed to simply maximize 
sensitivity (by allowing overlapping of projections) and to provide fluorescent counts from a ROI. 
This system would require guidance from CT or another modality to determine the ROI in this 
case, however, but then high sensitivity acceptable for in vivo application can achieved 














 : EVALUATING ENERGY-MULTIPLEXED EXCITATION 
SCHEMES FOR NANOPARTICLE-MEDIATED X-RAY INDUCED 
PHOTODYNAMIC THERAPY 
4.1 Abstract 
This work investigates the possibility of selectively activating different types of therapeutic 
nanoparticle by irradiating the target with X-rays of different energies to achieve a multiplexed 
therapeutic delivery method for cancer. During the therapeutic delivery process, a highly 
collimated external X-ray beam is used to irradiate the target. Within this scheme, one can possibly 
optimize the energy characteristics of the irradiating X-rays, so that one could selectivity activate 
a specific type of NPs. The activation of these nanoparticles is considered proportional to their X-
ray luminescence or X-ray fluorescence yield.  We will experimentally demonstrate the feasibility 
of this selective activation scheme by using a bench-top X-ray imaging/irradiation setup to 
selectively active two types of nanoparticles developed for X-ray PDT that contains Y2O3:Eu3+ 
and LaF3:Tb3+ nanoscintillators. We found X-ray luminescence production was most effectively 
produced at lower energies while fluorescence was more dependent on the K or L-edge. 
Additionally, the authors also found 10 keV incident photons showed a preferential luminescence 
activation of Y2O3:Eu3+ over LaF3:Eu3+. 
4.2 Introduction  
This work explores the feasibility of using X-rays of different energies to selectively 
activate different types of therapeutic nanoparticle to achieve a multiplexed therapeutic delivery 
method for cancer. In recent years, there have been increased interests in nanoparticle-mediated 
X-ray induced cancer therapy. During the therapeutic delivery process, a highly collimated 
external X-ray beam is used to irradiate the target. The metal atoms within the NPs preferentially 
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absorb the incident X-rays and induce a local therapeutic effect through photosensitization, thermal 
ablation or other processes. 
With this scheme, it is possible to optimize the energy characteristics of the irradiating X-
rays, so that one could selectivity activate a specific type of NPs that contain certain metal 
elements. Furthermore, by fine-tuning the X-ray source (with different filters, monochromators, 
and tube voltages) and by using designing therapeutic NPs containing different metal elements, 
one could achieve a multiplexed combinatorial therapeutic delivery in real-time.     The X-PDT 
effect is expected to be directly proportional to the yield  
In this study, we will experimentally demonstrate the feasibility of this scheme by using a 
bench-top X-ray imaging/irradiation setup to selectively active two types of nanoparticles 
developed for X-ray PDT that contains Y2O3:Eu3+ and LaF3:Tb3+ nanoscintillators. We will use 
imaging and quantitative measurements to access specificity for the selective activation, and to 
confirm the combinatorial therapeutic delivery approach. 
4.3 Materials and Methods 
4.3.1 System Setup 
To conduct this study, the system was arranged using two detectors, a series of motors, and 
two X-ray sources. One of the X-ray sources is an Oxford Instrument Apogee-5500 microfocus 
polychromatic X-ray source with a tungsten anode that can operate at 50 kVp and 1 mA in a 186 
𝜇𝜇m FWHM beam.  This source placed directly above the second source, which is a monochromatic 
Xenocs Genix with a Mo target that emits the characteristic 17.4 keV X-rays from the anode. The 
Xenocs source can emit 25x106 photons per second in a 146 μm FWHM area. A precise overview 
of the dimensions for the geometry is seen in Figure 4.1. 
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To measure the X-ray luminescence yields coming from the nanoparticles, an electron-
multiplying CCD (EMCCD), Andor iXon 887, coupled with a demagnifying tube (DM tube) was 
also positioned perpendicular to the beamline.  The DM increases the surface area of the detector 
Figure 4.1: The image geometry above shows the two X-ray sources and the two 
detectors used to collect fluorescence and luminescence signal from the detectors.   
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and amplifies any incoming signal by demagnifying the incoming projection to 0.25x the original 
size. The EMCCD has 512 by 512 16 μm square pixels. 
Additionally, the Andor Zyla and the Amptek XR-100T, are attached to two linear motors, 
and placed across from the sources. The motors allow for the detectors to move vertically as well 
as perpendicularly to the beamline. The Andor Zyla camera has contains 2560 by 2160 square 
pixels of 6.5 μm pitch, and is coupled to a CsI scintillator to convert incoming X-rays to visible 
light for the CMOS camera to detect.  The Andor Zyla is used to line up the nanoparticle sample 
along the beamline.  
The Amptek XR-100T is a single pixel CdTe detector of 1 mm thickness and 5 mm by 5 mm 
pitch. The CdTe detector has ~100% photoelectric absorption from 5 keV to 100 keV [61]. Since 
the setup is predominantly used for low energy X-ray imaging, the Amptek CdTe detector proves 
ideal for our purposes. The Amptek detector CdTe detector was used to acquire spectra of the 
incident beam, the beam being attenuated by the sample, and the incident XF.  In later studies, the 
detector is used to roughly estimate the dosage applied to the sample. The setup only had one 
Amptek XR-100T detector in hand so the detector position was switched between being in middle 
of the beamline for the estimated “dosage” calculation and being adjacent to the beamline to collect 
fluorescence.  
4.3.2 Sample 
The nanoparticles, Y2O:Eu3+ and LaF3:Tb3+, were each placed as powders in micropipette 
tips, model number 3120000020, from Eppendorf. The tips were completely filled with the NP’s 
and a copper marked region was placed 1.5 cm from the bottom of the pipette. The copper marker 
was used to ensure both samples were hit by the X-ray beam in the same position. The sample is 
seen in Figure 4.2.  
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4.3.3 Energy Selection 
The 17.4 keV X-rays from the monochromatic X-ray source matches very well with the K-
absorption-edge at 16.4 keV of yttrium (from Y2O3:Eu3+ NPs). We have experimented with the 
polychromatic X-ray source with cerium/aluminum and tungsten/aluminum filter combinations to 
create a relatively narrow energy distributions around 36 keV (with Ce/Al filter) and around 40 
keV (with W/Al filter). These X-ray energy bands are selected for selectively activate LaO3:Eu3+, 
since the K-edge of La is at 32 keV. In addition, the polychromatic source was also running at 
different tube voltages ranging from 10 kVp to 50 kVp to optimize the selectivity for activating 
each of the two types of NPs.  
Three different sets of excitation schemes were specifically in this study, as to stimulate the 
production of XF and XL signal from the samples:  
Figure 4.2: The pipettes were 




1) The polychromatic tube without filtration is the first set of excitation schemes used in this 
measurement. The tube was operated at its maximum current of 1 mA for the X-ray luminescence 
and fluorescence condition from 10 kVp to 50 kVp with increment steps of 5 kVp each time. 
Therefore, nine sets of tube voltage were use: 10, 15, 20, 25, 30, 25, 40, 45 and 50 kVp. The 
varying voltages affected parameters such as the maximum flux of photons, the maximum energy 
of the photons, and the average energy of the photons. 
  
2) The X-ray polychromatic source was then filtered by three different materials, in various 
combinations and thicknesses to attenuate the beam, before irradiating the various samples. The 
three materials used were cerium (K-edge = 40.41 keV), aluminum (K-edge = 1.56 keV) and 
tungsten (L-edge = 12.92 keV). They were chosen to attenuate the outgoing X-rays to 
monochromatize the beam as much as possible around the energies of the K-edges of the two 
nanoparticles in order to maximize the NPs’ photoelectric absorption.  
 
The actual filter configurations are as follows:  
• 100 μm of Ce  
• 200 μm of Ce  
• 200 μm of Ce and 5 mm of Al  
• 200 μm of Ce and 10 mm of Al  
• 100 μm of W;  
• 100 μm of W and 3 mm of Al  
• 100 μm of W and 5 mm of Al  
 
It must be considered that the filtering not only changes the energies of the photons of the X-ray 
cone beam—by mainly attenuating the low energy ones and those at K-edges or L-edges of the 
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filters—but  it also reduces the total flux of radiation illuminating the sample.  For these set of 
measurements, the polychromatic X-ray tube was operated at 50 kVp and 1 mA.  
3) Lastly, we used the monochromatic source (17.48 keV energy), operating at 50 kVp and 1 mA 
of tube current.  
4.3.4 X-ray Fluorescence 
The Amptek XR-100T CdTe detector was used to collect the XF fluorescence coming from 
the NP’s. The CdTe detector was placed 5 cm away from the sample and placed perpendicular to 
the beamline.  The CdTe detector was ran for 120 seconds for the cases without the filtering, and 
600 seconds when filtering is implemented due to the lower flux. Both the polychromatic tube and 
monochromatic tubes was operated at 0.01 mA to prevent saturation of the detector.   
To account for scattering from the sample, an empty plastic tube was placed into the 
beamline and the scattered photons were collected by the CdTe detector. Then the sample 
containing the nanoparticles was placed into the beamline and the resulting X-ray fluorescence 
was measured.  This was done for all incident energy configurations.  
The scattered spectrum is then subtracted off the spectrum produced with the NPs within 
the beamline. An example of this is seem in Figure 4.3, where the top left plot depicts the scattered 
beam profile of the 50 kVp empty tube while the top right plot depicts the combined X-ray 
fluorescence and scattered from the tube containing Y2O3 NPs. The bottom plot in the figure 
depicts the subtraction of the top two plots. Additionally, an average of the spectral points 500 eV 
above and below each peak was subtracted from the plot to account for scattering from the NPs 
themselves (which the empty tube subtraction cannot account for). Everything within the energy 
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windows for the metals of interest are counted towards the fluorescence count rate for that energy 
configuration.  
4.3.5 X-ray Luminescence Acquisition and Processing 
The X-ray luminescence is collected by the DM tube and the EMCCD. The EMCCD 
frame’s acquisition time and exposure time per frame varied depending on the signal strength of 
resulting luminescence.   
A suite of codes developed in MATLAB and C are used for processing the X-ray 
luminescence data acquired with the EMCCD plus DM tube of the XFCT/XLCT system. The raw 
Figure 4.3: The X-ray fluorescence was calculated by first obtaining the scattering spectrum from the empty 
tube as well as from the sample. The scattered spectrum was subtracted from the XF spectrum. Finally, as 
another means of subtracting the XF fluorescence data the regions above and below the fluorescence peaks are 
used to calculate a scattering baseline to subtract from the spectrum as well.       
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data frames (consisting of 512 by 512 pixels) taken with the EMCCD assembly during experiments 
to correct for dead pixels, a shifting, pedestal, and hot pixels.  
The pedestal and any ambient background signal can shift over time. The pedestal shifts 
are predominantly due to to electronic noise, dark currents in the detector. Additionally, the signal 
detected by each pixel, outputted in analog-to-digital units (ADU), also can differ as the 
probability for an optical photon to reach a specific pixel in a specific frame at a given time can 
vary pixel to pixel. In conclusion, this means that each pixel has individual behavior as well as the 
entire detector. Therefore, a constant tracking of the variation of the pedestal noise  for the frame 
and for each pixel and over the entire acquisition time is necessary, in order to correctly calculate 
the detected XL signal. In order to track the background during acquisition, the image acquisition 
process alternates between acquiring alternated sets of frames with X-ray excitation (X-ray ON) 
and sets with no X-ray excitation (X-ray OFF).  
The XL data processing procedure here proposed has three main tasks concerning the 
correction of the acquired X-ray luminescence frames, which are illustrated in the following list:  
1) Pedestal noise calculation—the first order and second order pedestal is calculated by 
keeping track and re-average the most recent 50 frames.  
2) Dead/Hot Pixel Correction—Hot pixels can be found by comparing an individual 
pixel’s average (over multiple frames) compare to the entire frame’s average over multiple 
frames. If the pixel strays significantly above or below a certain threshold (data 
3) DM Tube Discharge-The DM tube can release an electric discharge that can saturate 
a large cluster of pixels in the system (with saturating being 16,384 ADU). The tube 
discharge can be found by looking for a large cluster of saturated pixels. 
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An example of the pedestal correction is seen in Figure 4.4. Only a 16 by 16 ROI is 
examined here as an example. The pedestal correction code uses raw background frames (with the 
X-ray turned off) to update the pedestal. This raw data is depicted in the first row of the figure as 
a frame, plot, and histogram. The average of the previous background frames plus the current 
frame (after subtracting pixels too high or too low to be background) are then used to calculate the 
current pedestal value seen in the second row. Throughout these calculations if a pixel records an 
ADU value great than 20% than the current value of the frame background average, the code 
assumes the pixel is acting abnormally for the given frame. If this happens more than 50% of the 
time, the pixel is assumed to be an abnormal (dead/hot) pixel, and is not included in any of the 
frame average calculations. The third row shows the final data after the pedestal is subtracted from 
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Raw Frame Raw Data Plot Raw Data Histogram 
Pedestal Data Histogram Pedestal Plot Pedestal Frame 
Final Plot Final Histogram Final Frame 
Figure 4.4: An example of the pedestal correction for the EMCCD/DM tube assembly. Only a 16 by 16 ROI is 
examined here for illustrative purposes. The first row depicts the initial raw data background as a frame, plot, and 
histogram. The C code uses earlier obtained background frames and incorporates the current frame into the pedestal 




 This data can thus be evaluated at a frame by frame basis over time. This is seen in Figure 
4.5  The figure depicts the variation in time for the XL signal from the yttrium based NPs irradiated 
by the 50 kVp polychromatic source. The red shows the varying signal while the green depicts the  
mean while the X-ray source is on while  the blue and yellow work similarly for the X-ray off 
scenario. The magenta shows the result of subtracting the two means. When examining the X-ray 
Off and X-ray On signals, no periodicity is seen in the variation of the signals, which indicates the 
pedestal correction is working relatively well. The mean subtracted signal over time can be 
Time-Variation of XL Signal from Y2O3:Eu3+ at 50 kVp 
Figure 4.5: The figure depicts the variation in time for the XL signal from the yttrium based NPs irradiated by the 
50 kVp polychromatic source. The red shows the varying signal while the green depicts the  mean while the X-ray 
source is on while  the blue and yellow work similarly for the X-ray off scenario. The magenta shows the result of 
subtracting the two means. 
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converted to ADU/s given the known exposure time for the acquisition. The ADU/s serves as our 
luminescence signal rate that will be reported in this work’s results.  
4.3.6 Attenuated Energy Calculation 
This work does not perform a dosage calculation through dosimeters. Instead, the Amptek 
XR-100T CdTe detector is placed in the beamline. The beam-size is significantly smaller than the 
5 mm surface area of the detector, and thus the entire flux sent to the sample can be measured. A 
2 mm wide, 2 mm thick tungsten pinhole collimator is also placed in front of the detector to prevent 
any photons scattered by the sample by a wide angle from entering the detector. The CdTe detector 
then measured three samples (an empty micropipette tip, LaF3:Tb3+ filled, and Y2O:Eu3+) for 120 
seconds for all incident energy schemes. When using the unfiltered polychromatic and 
monochromatic X-ray sources, the tubes’ currents were operated at 0.01 mA to prevent saturation 
of the detector. When they were filtered, the tubes’ currents were set to 0.1 mA. Since the profile 
of the incident spectrum does not change with current (only the overall amplitude), the spectrum 
can be scaled to its full power equivalent by directly multiplying by either 100 (for the unfiltered 
cases) or 10 (for the filtered cases).  
To calculate the rate of energy attenuated per second—which the authors assume is directly 
proportional to dose—the spectrum containing the NP’s is subtracted off the empty tube spectrum 
for each given incident X-ray energy configuration. This is seen in Figure 4.6. The plot in the top 
left shows the spectrum (in counts per second) of the empty tube irradiated by the polychromatic 
source operating at 50 kVp tube voltage. The plot in the top right shows the spectrum of the 
Y2O3:Eu3+ NPs attenuating the beamline. The yttrium K-edge of 17.02 keV is quite apparent in the 
spectrum. Both spectra displayed account for detector deadtime. The subtracted spectrum of these 
two figures is shown in the bottom. The subtracted value should approximate how much energy 
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per second is attenuated by the NPs while accounting for any attenuation by their micropipette tip 
container. The summation of the counts for each energy channel in bottom spectrum of Figure 4.6  
equates to the energy attenuated by the sample per second. This value is imperative in 
understanding which incident X-ray schemes are the most efficient at producing X-ray luminesce 





Figure 4.6: The plot in the top left shows the spectrum (in counts per second) of the empty tube irradiated by the polychromatic 
source operating at 50 kVp tube voltage. The plot in the top right shows the spectrum of the Y2O3:Eu3+ NPs attenuating the 
beamline. The subtracted spectrum of these two plots is shown in the bottom. 
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4.4 Results  
The datasets for this data can be seen in the many figures below. For instance, for X-ray 
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LaF3 X-ray Luminescence vs. Attenuated Energy
(A) 
(B) 
Figure 4.7: The graphs depicts the X-ray luminescence output rate (ADU/s) and Attenuated Energy Rate in (keV/s) 
for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. 
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fluorescence rate can be seen in Figure 4.8.  Each point on the line graphs is a 5 keV increment in 
the tube voltage starting at 10 keV and ending at 50 keV. 
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Figure 4.8: The graphs depicts the X-ray fluorescence output rate (counts/s) and Attenuated Energy Rate in (keV/s) 
for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. 
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  Figure 4.9 shows the X-ray luminescence rate vs average attenuated energy for each 
configuration scheme for both nanoparticles.  While Figure 4.10 shows similar information for 
the fluorescence equivalent.  
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Figure 4.9: The graphs depicts the X-ray luminescence output rate (ADU/s) and average attenuated energy in (keV) 
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Figure 4.10: The graphs depicts the X-ray fluorescence output rate (counts/s) and average attenuated energy in 
keVfor (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. 
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 Figure 4.11 shows the energy-normalized X-ray luminescence rate vs the attenuated 
energy for each configuration scheme for both nanoparticles. This normalized value is produced 
by taking the original luminescence rate and dividing by the energy attenuated by the sample per 
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 Energy-Normalized X-ray Luminescence vs. Attenuated Energy(A) 
(B) 
Figure 4.11: The graphs depicts the energy-normalized X-ray luminescence output rate (ADU/keV) and attenuated 
energy in keV/s for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. The normalization is produce by taking the X-ray luminescence 
output rate and dividing by the attenuated energy rate for each data point. 
69 
 
second for each of the incident energy configurations. While Figure 4.12 shows similar 
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Figure 4.12: The graphs depicts the energy-normalized X-ray fluorescence output rate (counts/keV) and attenuated 
energy in keV/s for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. The normalization is produce by taking the X-ray fluorescence 





  Figure 4.13 shows the energy-normalized luminescence signal versus the average 
attenuated energy of the samples. The energy-normalized luminescence signal depicts the 
efficiency of the incident energy scheme.   
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Figure 4.13: The graphs depicts the energy-normalized X-ray luminescence output rate (ADU/keV) and average 
attenuated energy in keV/s for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. The normalization is produce by taking the X-ray 
luminescence output rate and dividing by the attenuated energy rate for each data point. 
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Figure 4.14 shows the energy-normalized fluorescence signal versus the average 
attenuated energy of the samples. The energy-normalized fluorescence signal depicts the 
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Figure 4.14: The graphs depicts the energy-normalized X-ray fluorescence output rate (counts/keV) and average 
attenuated energy in keV/s for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+. The normalization is produce by taking the X-ray 
fluorescence output rate and dividing by the attenuated energy rate for each data point. 
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Figure 4.15 shows the ratio between X-ray luminescence and fluorescence for each NP 
over various configurations.  This was simply obtained by divided the luminescent yields by the 





Figure 4.15: The figure shows a ratio of luminescence versus fluorescence for (A) Y2O3:Eu3+ and (B) LaF3:Tb3+.  
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 Lastly, a ratio of luminescence yields for the two nanoparticles at the maximum tube energy 
is shown in Figure 4.16A and the analogous plot for fluorescence is seen in Figure 4.16B 
 
Figure 4.16:  (A) shows how the different tube voltages affected the ratio of luminescent yield for both the NP’s. (B) 





4.5 Discussion and Conclusions 
Figure 4.7, Figure 4.8, Figure 4.9, and Figure 4.10 all show expected results. Figure 4.7 
simply shows that higher fluxes produce higher luminescent yields; Figure 4.9 shows that higher 
average energies produce higher luminescent yields. Figure 4.8 again shows that higher fluxes 
produce higher fluorescent yields; Figure 4.10 once more shows that higher average energies 
produce higher fluorescent yields. However, for both fluorescence datasets, no fluorescence is 
produced until the photon energies are higher than the K-edge of the specific nanoparticle.  
Figure 4.11 and Figure 4.13 shows that filtering and higher average energies may actually 
be inefficient in producing luminescence. The lower energies, although not necessarily the lowest, 
proved to be significantly more efficient at producing luminescence. Figure 4.12 and Figure 4.14 
showed that energies slightly above the K-edge energies of the NPs were most effective for 
producing fluorescence. This means the monochromatic sources was the most effective for 
yttrium’s production of fluorescence at 16.2 keV and luminescence at 9.8 keV. For lanthanum, 
production of fluorescence at 38 keV and luminescence at 12.7 keV.  
Various literature on the subject of X-ray luminescence suggest that light production is 
more dependent on the production of excited electron states than photoelectric absorption [75], 
[76].  When high energy X-rays excite and liberate electrons, these electrons can liberate other 
electrons former a cascade of secondary, tertiary, and so on generations of electrons. A possible 
reason why the higher energies are less efficient may be due to a fraction of the photon energy 
being lost to other mechanisms for each generation of excited electrons. Thus, there’s an 
exponential loss of energy for the number of generations of excited electrons produced.  
For higher energy X-ray fluorescence, the process is known to be related to the 
photoelectric effect. Energies significantly higher than the K-edge of the NP’s are unlikely to 
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produce more than one fluorescent photons. Thus, higher energy photons, though may be useful 
in thicker sample sizes, would not produce significantly more photons than photons right above 
the K-edge.   
Figure 4.15 shows how X-ray luminescence dominates over fluorescence at lower 
energies. For yttrium, the energy is about 9.8 keV for maximum luminescent yield over 
fluorescence. For lanthanum, the energy is about 12.7 keV for maximum luminescent yield over 
fluorescence. If one assumes for X-PDT that luminescent yield is the most indicative factor of 
therapeutic effectiveness from this dataset, then Figure 4.16 indicates that the 10 kVp energy 
maximizes yttrium’s luminescent yield over lanthanum. For fluorescence, yttrium can be selected 
over lanthanum by running the tube at 30 kVp. 
The results from this study show that specific incident photon energies are more conducive 
for producing luminescence in each of the nanoparticles. In short, energies around 10 keV seemed 
to be much more effective at luminescence production that energies at say 50 keV. Additionally, 
the data also indicates that one can selectively induce luminescent production in Y2O3:Eu3+ NP’s 
over LaF3:Tb3+ by 5.5 fold by selecting 10 keV. This work thus demonstrates a potential for 





 ENERGY-MATCHING X-RAY FLUORESCENCE COMPUTED 
TOMOGRAPHY: AN EVALUATION OF THE EFFECTS OF THE 
INCIDENT BEAM ENERGY ON IMAGING PERFORMANCE OF 
NANOPARTICLES 
5.1 Abstract 
This work examines the effect of various incident beam spectra on the image quality of X-
ray fluorescence computed tomography. Samples containing yttrium nanoparticles and hafnium 
nanoparticles were examined. To accomplish this, a semi-theoretical model was produced to 
determine which filtering configurations would work optimally for a given estimated energy 
attenuated. Results showed a good match between the experimental data and the semi-theoretical 
model. The monochromatic beam proved most efficient for both hafnium and yttrium. However, 
with appropriate filtering, a polychromatic source can get appreciable results. Further work 
includes expanding the semi-theoretical model to account for attenuation in thicker samples, and 
an examination at higher energies. 
5.2 Introduction 
Researchers have shown growing interest in X-ray fluorescence computed tomography 
(XFCT) due to its ability to image metals of interest without destroying the sample at respectable 
imaging depths, resolution, and sensitivity. X-ray fluorescence (XRF) occurs when externally 
applied X-rays cause the production of secondary characteristic X-rays. This process takes place 
when an incident X-ray causes an ejection of an inner shell electron through the photoelectric 
effect. The vacancy is filled by an outer shell electron, and the energy difference between the two 
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electrons’ orbitals causes the emission of a characteristic X-ray, which can be used to identify 
elemental composition of the target sample. 
While XRF has found a diverse range of biological applications, XFCT has been 
predominantly explored for its the potential to image the biodistribution and therapeutic 
efficaciousness of anti-cancer drugs such as platinum and gold nanoparticles [36], [63], [77], [78]. 
Gold nanoparticles (GNP’s) have specifically been investigated heavily with XFCT as gold has 
high specificity than conventional contrast agents, relatively high quantum yields, high 
photoelectric absorption, and penetrative XRF photons [36].     
Yet, the relatively low sensitivity of XFCT has inhibited the modality from systemic in vivo use 
thus far [42]. For instance, for GNPs, therapeutic concentrations within the tumor are on the order 
of 10 μg/ml (.001% wt)  ([42], [71]) , while recent benchtop ex vivo XFCT study only demonstrated 
the ability to detect concentrations around .25% gold by weight (2.5 mg/mL) [36]. Thus, the 
sensitivity must be significantly improved to make XFCT applicable in the pre-clinical/clinical 
setting. 
 This work investigates specifically how the incident X-ray beam spectra (filtered, 
monochromatic, etc) can affect the signal-to-noise ratio (SNR), and therefore the sensitivity, of the 
system. We propose, therefore, (1) a semi-theoretical model for estimating a SNR value for given 
incident X-ray spectra and element of interest i.e. yttrium and hafnium, (2) an experimental 
evaluation of these schemes on the XRF spectra, and lastly (3) an imaging study of a plastic mouse 
phantom with an yttrium or hafnium nanoparticle loaded channel to examine the incident beam’s 
effect on image quality through SNR and contrast-to-noise ratio (CNR).  In both the semi-
theoretical and experimental cases, a 17.4 keV monochromatic source will also examined as one 
of the incident beam profiles. The energy of this source is right above the K-edge of yttrium (17.07 
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keV), which we believe would provide a greater fluorescent yield. Any advantages to such 
“energy-matching” will also be examined. 
5.3 Materials and Methods 
5.3.1 Experimental Setup 
A benchtop XFCT setup will carry out these studies as seen in Figure 5.1. The setup 
contains multiple detectors and two X-ray sources. One X-ray source is polychromatic with a 
tungsten target, and capable of running up to 50 kVp and 1 mA. The output of the source can be 
modified by filtration. Additionally, the setup also includes a monochromatic X-ray source capable 
of producing X-ray photons of the single 17.4 keV Mo Kα energy. At the sample location, the 
monochromatic pencil beam is focused to a 168 μm FWHM with 2.4 ×106 photon/s total being 
emitted through the source and polychromatic source has a 187 μm FWHM. 
Figure 5.1 The figure depicts an overview of the XFCT setup which contains both a polychromatic and 
monochromatic source, an Amptek XR-100T  CdTe detector which can be positioned across the beam, 
and an Andor iKon-L CCD camera to capture XF emission.  
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Aside the from the sources, two specific detectors are also used in the study. The Amptek 
XR-100T CdTe detector allows for measuring the incident X-ray energy spectrum. This detector 
also enables us to know how many photons of each energy is attenuated by the sample; this 
provides a rough understanding of dose. In addition to this, an Andor DO-936 CCD camera is also 
set perpendicular to the beam line to collect XF emission. The CCD is also coupled to an aperture 
with its 350 μm slit oriented perpendicular to the beam, which collects the XF signals from a 
known region constrained by the slit and pencil beam size. This imaging scheme permits the direct 
mapping of the XF photons into image space without reconstruction. The CCD contains a sensor 
area of 2048 × 2048 square pixels of 13.5 µm × 13.5 µm in size.  
5.3.2 Semi-theoretical Calculation 
In order to calculate a semi-theoretical SNR, various filter and kVp configurations of the 
incident X-ray spectra are measured using the CdTe detector. The configurations include 
combinations of cerium, tungsten, aluminum, and copper filtration measured at 20 kVP to 50 kVp. 
Since, this model calculates a relative SNR of a given geometry, the samples’ thickness are 
considered negligible. Additionally, in our experimental evaluation, the sample size is 
approximately 1 cm, with the incident beam path only traveling 2-3 mm through plastic before 
reaching the 400 μm thick NP region. 
The acquired spectra are distributed across Bmax channels in the MCA. First, to take into 
account of the potential for the photons to down-scatter into a each channel, Equation 1 is used. 
f(j) represents the number of counts in a given channel while fds is the number of counts that are 
found within a channel after accounting for the probability of a single Compton scattering event. 
𝜎𝜎cs is the probability of a photon in the given channel j scattering into the energy of channel B. 
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This probability is the product of the Compton scattering cross section of ABS plastic with the 
Klein-Nishina formula for 0 to 360° of scattering.  
Equation 5.1: 






The total energy attenuated by the sample per second, K, can be estimated then by summing 
across all channels the product of f(B), E(B), and μ(B) as seen in Equation 5.1.  f(B) is the number 
of counts per second given in channel B, E(B) is the average energy of channel B, and μ(B) is total 
linear attenuation coefficient for this channel’s energy. The total linear coefficient is obtained from 
the XCOM database available online [74]. 
  
Equation 5.2: 





Dividing f(B) by K provides a normalized incident energy spectrum, fK(B). The signal 
value, S, can then be obtained by as seen in Equation 5.2 with the photoelectric cross-section Γ(B) 
of the element of interest at a given energy, and summing from the K-edge of the element to the 
spectrum’s maximum energy. 
Equation 5.3 







The noise, N, can be calculated using Equation 5.3 with the scattering cross-section (σ) of the 
plastic, and EPeak being the energy characteristic peak of the element of interest.  The product of 
the normalized spectrum and the linear scattering coefficient is summed for all the channels that 
lie within a 3 keV window centered on the characteristic peak. 
 
Equation 5.4 



























Figure 5.2: (A) The original unattenuated spectra of the polychromatic source is collected via the Amptek detector. 
The characteristic tungsten peaks from the source are observed. (B) The spectrum takes into account a single scattering 
event by the incident beam. (C) The total attenuation cross section was obtained from XCOM  and plotted against the 
energy channels depicted. (D) The data from 2B and 2C are multiplied together with sample density taken into account. 
(D)  The data from Figure 2A is normalized by dividing by the integrated value of Figure 2C. (E) The normalized 
spectrum seen in D is then multiplied by the photoelectric cross section to produce a signal spectrum, which provides 
a value proportional to the signal obtained. (F) Likewise, the normalized spectrum seen in D is multiplied by the 
scattering cross section obtain from XCOM to produce a probability obtained.  
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5.3.3 Experimental Validation of the Semi-Theoretical Results 
The semi-theoretical model is tested by experimentally testing five to six different filter 
configurations, which vary in estimated SNR efficiency. The sample is a small 1-cm diameter 
mouse phantom with a polyethylene tube filled with either Hf or Y nanoparticles placed 2 mm 
deep within the mouse phantom. The polyethylene tube has 600 μm outer diameter and a 400 μm 
inner diameter.  
The experimental data points to test were determined as a balance of acquisition time and 
for a relatively even dispersal of points across the semi-theoretical. Thus, the polychromatic source 
ran at 50 kVp, 40 kVp with .50 m of W filter, 40 kVp with 1 mm Ce filter, 40 kVp with 1 mm Al 
and .050 mm Ce filter, and 30 kVp with 1 mm Al filter for collecting the yttrium SNR data 
experimentally. For the hafnium, the polychromatic source ran at 50 kVp  with 1 mm Al and .025 
mm W filters, 40 kVp with 1 mm Al and .025 mm W filters, 50 kVp with 1 mm Al filter, 40 kVp 
with 1 mm Al filter, and 30 kVp .050 mm Ce filter. The monochromatic source was also used in 
both cases.   
The CCD camera is placed perpendicular to the collimated beamline for the polychromatic 
and monochromatic source.  Across from the beamline is the CdTe detector, which measures for 
5 minutes the no sample in the beamline (Figure 5.3A) as well as with the sample in the beamline 
(Figure 5.3B). The subtract of the two spectrum shows us the spectrum of the photons attenuated 
or removed by the sample per second (Figure 5.3C), which is assumed to be proportional to dose.  
The integration of this spectrum provides an estimated dosage, Kexp, used to normalize the SNR of 
the incident irradiation schemes.   
The CCD, which is coupled to a 300 μm slit, collects the emitted X-ray fluorescence as 
well as the incident beam scattering from the sample. To experimentally evaluate the SNR, the 
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CCD was set to have 5 second exposure time per frame with a varying amounts of overall 
acquisition time to ensure that the fluorescence counts and scattered noise counts exceed 525 to 
ensure an error of less than 5%.  
The CCD functions as a photoncounting detector; thus, a per pixel spectrum can be 
obtained. The detector is run using 2x2 binning changing the effective pixel size to 26 µm square 
pixels in a 1024 by 1024 array. The events are also corrected for charge sharing as described in a 
previous work[41].  For each filtering configuration, an accumulation of events can be obtained as 
seen in Figure 5.4A.  The red boxes in the in the projection depict where in beam is hitting either 
 
Figure 5.3: Example spectra obtained by the Amptek CdTe detector for the unfiltered 50 kVp 
polychromatic source are obtained with (A) depicting the spectrum with no sample in the beamline. (B) 
shows the spectrum once the sample with the polyethylene tube centered in the collimated beamline. (C) 
depicts the result of subtracting (B) from (A), which allows us to observe the energy per second being 
removed by the sample. 
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the plastic portion of the mouse or the nanoparticle containing region. A spectrum for each region 
can also be obtained as seen in Figure 5.4B. Counts within the a 14.75 to 15.25 keV window 
centered on the yttrium Kα1 peak was counted as signal while counts in a 3 keV window centered 
on the same peak in the plastic mouse region contributed to “noise counts.” To calculate the SNR, 
Equation 5.6 is used, with S referring the CPS of counts within the fluorescence window within 
the nanoparticle region of the projection while N refers to the counts within the 3 keV window 
occurring within the plastic region of the projection. Kexp is the earlier described estimated dose 




























Figure 5.4: (A) A projection of all accumulated events on the CCD detector. The red box on the left 
represents the region of the detector corresponding to counts originating from the plastic of the mouse 
while the region on the right responds counts corresponding to the nanoparticle region of the sample. 
(B) The resulting spectrum from each region of the detector. Counts within the a 14.75 to 15.25 keV 
window centered on the ytrrium Kα1 peak was counted as signal while counts in a 3 keV window 





5.3.4 Imaging Experiment Setup and Methodology 
As a final evaluation of the incident spectrum’s effect on image quality, a single XFCT 
slice using three of the incident spectra schemes from the earlier experimental measure were 
obtained. The sample for these measurements is the same plastic mouse phantom described in the 
previous section. The mouse phantom had four polyethylene tubes filled with deionized water, 
1.057 mg/mL, 12.7 mg/mL, and 131.9 mg/mL yttrium solutions. The yttrium solutions were 
prepared by dissolving yttrium(III) nitrate hexahydrate in water to produce the mentioned 
concentrations. 
  The CdTe detector was used to estimate the dosage using the earlier described 
methodology. The attenuation of the sample was measured with the 131.9 mg/mL yttrium tube 
centered in the beamline.  
The CCD coupled with the 300 μm wide tungsten slit aperture was used to collect the X-
ray fluorescence photons. The same axial slice of the mouse sample was acquired by scanning the 
mouse in 200 micron steps for all three filter configurations. The overall experimental geometry 
is observed in the Figure 5.5.  
5.3.5 Image Production, Scatter-Subtraction, and Analysis 
The system scans in 200 micron steps, with each step producing an event-accumulated 
projection such as the one Figure 5.4A. Since a slit aperture is attached to the detector and a pencil 
beam is irradiating the sample, each column of pixels corresponds to a voxel along the beam line 
in the object space. Thus, in post-processing, each event accumulated projection is binned into 
super pixels of 4 columns in width. Therefore, one step (which is equivalent to one project) will 
provide a row of 256 voxels in object space.   
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In order to remove the scatter contribution from the image, and improve the contrast-to-
noise ratio of the image (CNR). In post-processing, the spectrum for each super-pixel is analyzed 
and a baseline is established to remove the contribution of scatter from the incident beam. First, a 
window, from 14.7 keV to 15.4 keV, is placed around the yttrium Kα1 peak for the plotted spectrum 
for each super-pixel (seen as black lines in Figure 5.6). All counts within the energy window will 
be considered fluorescence counts for the super-pixel, even though scatter from the incident beam 
will produce noise. To compensate for this, points (represented as black circles in Figure 5.6) on 
the spectrum 500 eV above and below the energy window are used to fit a line (represented by the 
slanted red line in Figure 5.6). The area below the line within the energy window is subtracted 
from the data to reduce the scatter contribution. This process is repeated for each super pixel until 
the final image is produced.   
 In the image, the SNR was calculated by comparing counts within the known nanoparticle 
region and comparing it to counts in a region expected to be plastic. Equation 5.7 describes the 
 
Figure 5.5: The above figure describes the imaging geometry of the system. The sample a plastic mouse phantom 
with polyethylene tubes filled with yttrium or water inserted axially in the figure. The Amptek CdTe detector 
obtains attenuated information from the sample, which is used to estimate the dose while the CCD collects X-
ray fluorescence. The sample is translated in 200 μm steps to collect an entire slice. 
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calculation used for SNR, where SNP defines the counts coming from the Nanoparticle region of 
the image while Nplastic are the counts from the image that comes from a known plastic region. The 








 Similarly, for the image, CNR can also be calculated using the same known nanoparticle 
region and known plastic region. Equation 5.8 describes the calculation used for CNR, where μNP 
Figure 5.6: (A) A window from 14.7 keV to 15.4 keV is set to select 14.96 keV Kα1 peak of the yttrium in 
each super pixel. The scattering of the monochromatic peak is also visible. A linear fit for the points 500 
eV above is used to determine the baseline from the monochromatic beam scattering. (B) The results of 
the subtraction are depicted in this figure. 
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is the mean of counts coming from the pixels in the nanoparticle region of the image while μplastic 
is the mean of the counts of the pixels from the known plastic region. σplastic is the standard 
deviation of the counts for plastics within the plastic region as well. Both CNR and SNR are 
calculated for each observed nanoparticle region (i.e. 130 mg/ml, 12.7 mg/ml, etc.) for all three 
incident beam configurations used 









5.4.1 Semi-theoretical Model and Experimental Verification 
The results of the semi-theoretical model and the experimental verification for hafnium and 
yttrium are shown in Figure 5.7 and Figure 5.8.   For each figure, the left-hand blue scale indicates 
the relative SNR for the different configurations. The calculated SNR’s are normalized to the best 
performing incident beam configuration. The blue bars are the relative SNR determined from the 
semi-theoretical model while the red dot depict the experimentally determined SNR for that 
specific configuration. The green dots represent the relative flux of the beam in photons per second 
using a log scale seen on the right. The lower the value, the longer the acquisition time is needed 
to acquire an adequate image.  As earlier described, the calculated SNR’s are normalized for the 






















































































































































































































































































































































































































































































































































































































































































































































































5.4.2 Imaging Study Results 
The results of the imaging study are shown in Figure 5.9. The figure is divided into three 
columns with each column representing the results from one of the three incident beam 
configurations: monochromatic, 50 kVp, or 30 kVp with 1 mm Al. The first row of images in the 
figure represents the resulting fluorescence selected images using the procedure outlined in the 
imaging studies section for the different configurations. The acquisition time for all three of these 
images are adjust so that each image had the same amount of estimated energy attenuated by the 
sample. The image consists of 256 by 24 pixels. 
The second row of images takes the image from the first row, and applies a bicubic 
interpolation to “smooth” the image. The images are also on a log-scale in order to better capture 
the features across the vast range of counts. After interpolation, the image consisted of 1280 by 
1240 pixels. The last image shows the bicubic interpolated images overlaid over the CT image of 
the mouse.    
From the images, both CNR and SNR were calculated for the various concentrations of 
yttrium visible across the three different incident beam configurations. The results are shown in 
Table 5.1. 
 SNR CNR 
Concentration  (mg/mL) 131.9 12.7  1.06 131.9 12.7  1.06 
50 kVp 28.2 14.1 N/A 1188.6 269.0 N/A 
30 kvp 1 mm Al 62.2 31.9 N/A 7357.3 1441.0 N/A 
Monochromatic 92.27 45.4 13.5 191585.2 38717.1 600.1 




























Figure 5.9: The figure depicts the results of imaging a plastic mouse attached with four polyethylene tubes filled 
with deionized water, 1.057 mg/mL, 12.7 mg/mL, and 131.9 mg/mL yttrium solutions. Three different incident beam 
configurations are used: 50 kVp, 30 kVp, and the monochromatic beam. The images from each configuration are 
arranged in a column. 
(A-C) These are the resulting images from the imaging study following the outlined methodology. Each image was 
composed of 24 steps of 200 μm translations. The imaging time of each step varied to ensure that the overall 
estimated energy attenuated by the sample for each image was equivalent.  
(D-F) Given the pixelated nature of the images in A-C, bicubic interpolation was applied to the image to change the 
image from 256 by 24 to 1280 by 120 pixels. Additionally, the image was shifted to log-scale to better display the 
features with lower counts. 
 





5.5 Discussion and Conclusions 
The calculation of the semi-theoretical SNR’s matches relatively well with the 
experimental data collected. However, only five experimental data points were examined for each 
of nanoparticles tested. The semi-theoretical model used does not take into account attenuation of 
the incident beam or exiting fluorescent photons. The incoming and outgoing X-rays, in this case, 
only need to travel a 1-3 mm’s through the plastic mouse. Thicker samples would most likely cause 
greater discrepancies between the model and the experimental data.  
Additionally, both the semi-theoretical model and experimental verification showed that 
the 17.4 keV monochromatic beam was the most efficient at producing higher quality images. For 
yttrium, the monochromatic energy is right above its K-edge, this would provide higher 
photoelectric absorption and therefore greater yields. However, due to 17.4 keV monochromatic 
beam falling relatively close to the 14.96 keV Kα1 line of yttrium, significant scattering into the 
fluorescence energies contributed to noise.  Likewise, the 30 kVp source with 1 mm Al performed 
quite well for yttrium. The spectrum’s average energy of 21.4 keV, served as a quasi-
monochromatic source as well. 
With hafnium, only the L-energies were examined due to the low kVp nature of the X-ray 
sources used. Any photon with energies above the 11.2 keV L-I edge of hafnium could contribute 
to fluorescence in this case. The semi-theoretical data showed that while schemes that filtered 
lower energies were not as potent as the yttrium case, the higher kVp’s were less effective at 
producing fluorescence. The data shows the 40 kVp’s and 50 kVp’s configurations were relatively 
inefficient compare to the 30 kVp and 20 kVp schemes. This is most likely due to the lower 
probability of photoelectric absorption at higher energies whilst the photons still retaining the 
ability to deposit energy through scattering interactions. 
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The imaging results showed how significantly the incident beam can affect the image 
quality and SNR for a given energy attenuated by the sample. The polychromatic source ran at 50 
kVp worked expectedly poor when compared to the 30 kVp with 1 mm Al filter. However, in both 
cases the 1.06 mg/mL concentration of yttrium were not visible in the sample. The monochromatic 
incident beam proved to be the most effective as the 1 mg/mL polyethylene tube became clearly 
visible.  
However, in terms of SNR, the semi-theoretical model, experimental model, and imaging 
study, the monochromatic source did not perform significantly better than the quasi-
monochromatic source configurations (polychromatic with filtering). While this may be 
surprising, the higher probability of downscattering from the monochromatic source into the 
yttrium peaks can contribute to hinder a higher SNR performance. Additionally, considering the 
number of photons for the monochromatic source and 30 kVp with 1 mm Al source are similar, 
the likelihood of producing fluorescence and therefore signal would also perform similarly.  
Yet the monochromatic did prove much more effective in terms of CNR in the imaging 
study. The earlier described methodology used to subtract of the scattering component within the 
image itself significantly improves the CNR, but would minimally effect the SNR, which 
predominantly relies on signal strength. 
From the results given, energy-matching the incident beam with the element of interest 
enhances image quality. Thus, the monochromatic beam performs the best in the study, but 
filtering of polychromatic sources could be used to capture much of its advantages. Additionally, 
the semi-theoretical model can be used to estimate which configurations are best suited to 
experimentally test in imaging studies for samples sufficiently small. With the pencil beam XFCT 
geometry, using a CT image to determine the path length of incoming incident X-rays and outgoing 
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fluorescent X-rays, one can expand the semi-theoretical model to include attenuation, and improve 
its precision in thicker samples. The expanded model in conjunction with the proposed XFCT 
geometry would allow for optimization of incident X-rays without performing computational 
intense Monte Carlo simulations. With the expanded model, the same set of experiments should 
be conducted using higher energies that would be more practical for pre-clinical circumstance; 
hafnium’s K-edge for instance is at 65 keV, which is more practical in a pre-clinical setting. 
However, optimizing the incident energy spectrum is only one way of many for improving 
XFCT sensitivity sufficiently for preclinical imaging. Exploration in aperture design, and full-ring 

















 CONCLUSION AND FUTURE WORK 
The bulk of this dissertation examines the effects of incident energy spectra on image quality, 
luminescent yields, and fluorescent yields. This only shows a small portion of the factors that need 
to be addressed in bringing XFCT and XLCT to in vivo application. The sensitivity needs to still 
be further increased by improving geometric sensitivity, higher energy fluorescence needs to be 
further examined for mouse and human studies, dosage needs to decrease, and scan times must 
also be lowered. Additionally, the mechanisms for X-PDT’s therapeutic effects still have not been 
completely examined. The next two sections discuss a few future projects, which can push the 
envelope for XFCT and XLCT.  
The current CCD has appreciable sensitivity up to 20 keV. In order to move into X-ray 
fluorescence useable for the human body, a new detector and higher energy X-ray source must be 
used. This higher energy work will evaluate the use of the small-pixel CdTe detectors for XFET 
imaging with higher-energy (10-100 keV) fluorescence X-rays metals. These include a wide array 
of potential XPDT agents containing high-Z metal elements such as Au (68.8 keV Kα1), Hf (56 
keV Kα1), La (33.4 keV Kα1), Pt (66 keV Kα1) and Gd (43 keV Kα1). These corresponding X-rays 
could have the necessary penetration needed for XFCT to be capable of monitoring X-PDT 
delivery in deeper tissues.  
A CdTe detector produced from the HEXITEC collaboration has an active detection area 
of 2 cm × 2 cm, with its anode divided into 80×80 pixels with a pixel pitch size of 250 µm. The 
1mm thick CdTe detector offers an excellent energy resolution of around 1 keV and approximately 
100% detection efficiency for X-rays between 10 and 100keV.  
Experiments have already begun with testing these PDT nanoparticles containing 
Y2O3(Eu), LaF3(Tb), HfO2 and evaluating their use in XFET geometry at higher energies. The 
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work will begin by acquiring an XRF spectra of the samples described above using a 120 kVp W 
source. Next, the same setup will acquire an image using a slit aperture as described in the image 
mapping section in Chapter 2. Such work would ultimately provide a solid understanding of the 
feasibility of a XF/XL/CT system for clinical or preclinical use.  
Chapter 3 mentioned the possibility of incorporating a full-ring X-ray fluorescence 
system with multiple apertures. Such a system would greatly improve the sensitivity and image 
acquisition time for the system for a given dose. An example of such a system is seen in Figure 
6.1. Future work would include developing and characterizing the sensitivity and resolution of 
Figure 6.1: An illustrative 3D full ring system for XFET. 
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the XFET system.  Improvements in the geometric sensitivity and optimization of the incident X-
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